• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
67
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

Cracking the code-ing sequence for Parkinson’s disease

Jansen, I.E.

2017

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Jansen, I. E. (2017). Cracking the code-ing sequence for Parkinson’s disease.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ? Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

(2)
(3)

CHAPTER 6

Discovery and functional

prioritization of Parkinson’s

disease candidate genes from

large-scale whole exome sequencing

(4)

6

ABSTRACT

Background͗tŚŽůĞͲĞdžŽŵĞƐĞƋƵĞŶĐŝŶŐ;t^ͿŚĂƐďĞĞŶƐƵĐĐĞƐƐĨƵůŝŶŝĚĞŶƟĨLJŝŶŐ

ŐĞŶĞƐƚŚĂƚĐĂƵƐĞĨĂŵŝůŝĂůWĂƌŬŝŶƐŽŶ͛ƐĚŝƐĞĂƐĞ;WͿ͘,ŽǁĞǀĞƌ͕ƵŶƟůŶŽǁƚŚŝƐĂƉƉƌŽĂĐŚ has not been deployed to study large cohorts of unrelated subjects. To discover ƌĂƌĞWƐƵƐĐĞƉƟďŝůŝƚLJǀĂƌŝĂŶƚƐ͕ǁĞƉĞƌĨŽƌŵĞĚt^ŝŶϭ͕ϭϰϴƵŶƌĞůĂƚĞĚĐĂƐĞƐĂŶĚ ϱϬϯĐŽŶƚƌŽůƐƵďũĞĐƚƐ͘ĂŶĚŝĚĂƚĞŐĞŶĞƐǁĞƌĞƐƵďƐĞƋƵĞŶƚůLJǀĂůŝĚĂƚĞĚĨŽƌĨƵŶĐƟŽŶƐ ƌĞůĞǀĂŶƚƚŽWĂƌŬŝŶƐŽŶ͛ƐĚŝƐĞĂƐĞďĂƐĞĚŽŶƉĂƌĂůůĞůZEͲŝŶƚĞƌĨĞƌĞŶĐĞ;ZEŝͿƐĐƌĞĞŶƐ in human cell culture, and Drosophila and C. elegans models.

ZĞƐƵůƚƐ͗ ƐƐƵŵŝŶŐ ĂƵƚŽƐŽŵĂů ƌĞĐĞƐƐŝǀĞ ŝŶŚĞƌŝƚĂŶĐĞ͕ ǁĞ ŝĚĞŶƟĨLJ Ϯϳ ŐĞŶĞƐ ƚŚĂƚ ŚĂǀĞ ŚŽŵŽnjLJŐŽƵƐ Žƌ ĐŽŵƉŽƵŶĚ ŚĞƚĞƌŽnjLJŐŽƵƐ ůŽƐƐͲŽĨͲĨƵŶĐƟŽŶ ǀĂƌŝĂŶƚƐ ŝŶ W ĐĂƐĞƐ͘ĞĮŶŝƟǀĞƌĞƉůŝĐĂƟŽŶĂŶĚĐŽŶĮƌŵĂƟŽŶŽĨƚŚĞƐĞĮŶĚŝŶŐƐǁĞƌĞŚŝŶĚĞƌĞĚďLJ ƉŽƚĞŶƟĂůŚĞƚĞƌŽŐĞŶĞŝƚLJĂŶĚďLJƚŚĞƌĂƌŝƚLJŽĨƚŚĞŝŵƉůŝĐĂƚĞĚĂůůĞůĞƐ͘tĞƚŚĞƌĞĨŽƌĞ ůŽŽŬĞĚ ĨŽƌ ƉŽƚĞŶƟĂů ŐĞŶĞƟĐ ŝŶƚĞƌĂĐƟŽŶƐ ǁŝƚŚ ĞƐƚĂďůŝƐŚĞĚ W ŵĞĐŚĂŶŝƐŵƐ͘ &ŽůůŽǁŝŶŐZEŝͲŵĞĚŝĂƚĞĚŬŶŽĐŬĚŽǁŶ͕ϭϱŽĨƚŚĞŐĞŶĞƐŵŽĚƵůĂƚĞĚŵŝƚŽĐŚŽŶĚƌŝĂů ĚLJŶĂŵŝĐƐ ŝŶ ŚƵŵĂŶ ŶĞƵƌŽŶĂů ĐƵůƚƵƌĞƐ͕ ĂŶĚ ϰ ĐĂŶĚŝĚĂƚĞƐ ĞŶŚĂŶĐĞĚ ɲͲƐLJŶƵĐůĞŝŶ ŝŶĚƵĐĞĚ ŶĞƵƌŽĚĞŐĞŶĞƌĂƟŽŶ ŝŶ Drosophila. Based on complementary analyses ŝŶ ŝŶĚĞƉĞŶĚĞŶƚ ŚƵŵĂŶ ĚĂƚĂƐĞƚƐ͕ ϱ ĨƵŶĐƟŽŶĂůůLJ ǀĂůŝĚĂƚĞĚ ŐĞŶĞƐͶGPATCH2L,

h,Z&ϭWϭ>, PTPRH, ARSB and VPS13CͶĂůƐŽ ƐŚŽǁĞĚ ĞǀŝĚĞŶĐĞ ĐŽŶƐŝƐƚĞŶƚ ǁŝƚŚ

ŐĞŶĞƟĐƌĞƉůŝĐĂƟŽŶ͘

ŽŶĐůƵƐŝŽŶƐ: LJŝŶƚĞŐƌĂƟŶŐŚƵŵĂŶŐĞŶĞƟĐĂŶĚĨƵŶĐƟŽŶĂůĞǀŝĚĞŶĐĞ͕ǁĞŝĚĞŶƟĨLJ

(5)

6

/EdZKhd/KE

EĞdžƚŐĞŶĞƌĂƟŽŶƐĞƋƵĞŶĐŝŶŐĂƉƉƌŽĂĐŚĞƐŚĂǀĞƌĞĐĞŶƚůLJĂĐĐĞůĞƌĂƚĞĚƚŚĞŝĚĞŶƟĮĐĂƟŽŶŽĨ variants responsible for familial Parkinson’s disease (PD).1-4tŚŝůĞĂƉŽƐŝƟǀĞĨĂŵŝůLJŚŝƐƚŽƌLJ

ŝƐĐŽŵŵŽŶŝŶW͕ůĂƌŐĞ͕ŵƵůƟŐĞŶĞƌĂƟŽŶĂůƉĞĚŝŐƌĞĞƐ͕ĞƐƉĞĐŝĂůůLJǁŝƚŚĂǀĂŝůĂďůĞEĂŶĚ ĐůŝŶŝĐĂů ĞǀĂůƵĂƟŽŶƐ ƌĞŵĂŝŶ ĞdžĐĞƉƟŽŶĂů͕ ŚŝŶĚĞƌŝŶŐ ƉƌŽŐƌĞƐƐ ŝŶ ƵŶƌĂǀĞůŝŶŐ ƚŚĞ ŐĞŶĞƟĐ ƵŶĚĞƌƉŝŶŶŝŶŐƐ͘/ŵƉŽƌƚĂŶƚůLJ͕ƐĞǀĞƌĂůŐĞŶĞƐŝŶŝƟĂůůLJĚŝƐĐŽǀĞƌĞĚƚŽĐĂƵƐĞWŝŶĨĂŵŝůŝĞƐ͕ƐƵĐŚ as >ZZ<Ϯ͕'ĂŶĚWZ<ϮͬƉĂƌŬŝŶ, were subsequently discovered with surprisingly high frequency in “sporadic” PD cohorts.5,6dŽ ĚĂƚĞ͕ůĂƌŐĞƉŽƉƵůĂƟŽŶ ƐĂŵƉůĞƐ ŽĨ ŝŶĚŝǀŝĚƵĂůƐ

ǁŝƚŚWŚĂǀĞƉƌŝŵĂƌŝůLJĐŽŶƚƌŝďƵƚĞĚƚŽƚŚĞĚŝƐĐŽǀĞƌLJŽĨĐŽŵŵŽŶǀĂƌŝĂŶƚƐƵƐĐĞƉƟďŝůŝƚLJůŽĐŝ͕ ďĂƐĞĚŽŶŐĞŶŽŵĞͲǁŝĚĞĂƐƐŽĐŝĂƟŽŶƐƚƵĚŝĞƐŽĨĐĂƐĞͬĐŽŶƚƌŽůĐŽŚŽƌƚƐ͘7dŚĞǀĂƌŝĂŶƚƐŝĚĞŶƟĮĞĚ

ďLJ ŐĞŶŽŵĞͲǁŝĚĞ ĂƐƐŽĐŝĂƟŽŶ ƐƚƵĚŝĞƐ ;'t^Ϳ ŚĂǀĞ ŵŽĚĞƐƚ ĞīĞĐƚ ƐŝnjĞƐ ĂŶĚ ĐŽůůĞĐƟǀĞůLJ ĨĂŝůƚŽĂĐĐŽƵŶƚĨŽƌĐƵƌƌĞŶƚĞƐƟŵĂƚĞƐŽĨWŚĞƌŝƚĂďŝůŝƚLJ͘8,9 Considering the above, it seems

ůŝŬĞůLJƚŚĂƚĂĚĚŝƟŽŶĂůůĞƐƐĐŽŵŵŽŶĂůůĞůĞƐ͕ǁŝƚŚůĂƌŐĞƌĞīĞĐƚƐŝnjĞƐĐŽŶƚƌŝďƵƚĞƚŽWƌŝƐŬŝŶ ƚŚĞƉŽƉƵůĂƟŽŶ͕ĂŶĚŶĞdžƚŐĞŶĞƌĂƟŽŶƐĞƋƵĞŶĐŝŶŐŝƐŽŶĞƉƌŽŵŝƐŝŶŐĂƉƉƌŽĂĐŚƚŽŝĚĞŶƟĨLJ ƐƵĐŚĂůůĞůĞƐ͘ĞƐƉŝƚĞƌĞĐĞŶƚƐƵĐĐĞƐƐĞƐŝŶŽƚŚĞƌŶĞƵƌŽĚĞŐĞŶĞƌĂƟǀĞĚŝƐĞĂƐĞǁŝƚŚĐŽŵƉůĞdž ŐĞŶĞƟĐĞƟŽůŽŐŝĞƐ͕ŝŶĐůƵĚŝŶŐůnjŚĞŝŵĞƌ͛ƐĚŝƐĞĂƐĞ10-12 and amyotrophic lateral sclerosis,13, 14

sequencing has yet to be deployed in large, unrelated PD case/control samples for rare variant discovery.

dŚĞ ƐƵĐĐĞƐƐĨƵů ĚŝƐĐŽǀĞƌLJ ŽĨ ƌĂƌĞ ǀĂƌŝĂŶƚ ƌŝƐŬ ĂůůĞůĞƐ ŝŶ ƉŽƉƵůĂƟŽŶͲďĂƐĞĚ W ƐĂŵƉůĞƐĨĂĐĞƐĂŶƵŵďĞƌŽĨƉŽƚĞŶƟĂůĐŚĂůůĞŶŐĞƐ͘WĞƌŚĂƉƐŵŽƐƚŝŵƉŽƌƚĂŶƚůLJ͕ĂŶĂůLJƐĞƐŽĨ ƌĂƌĞǀĂƌŝĂŶƚƐŝŶůĂƌŐĞĨĂŵŝůLJƉĞĚŝŐƌĞĞƐŝƐŐƌĞĂƚůLJĨĂĐŝůŝƚĂƚĞĚďLJƐĞŐƌĞŐĂƟŽŶĂŶĂůLJƐŝƐǁŚŝĐŚ is not possible in cohorts of unrelated individuals, leading to an increased number of ĐĂŶĚŝĚĂƚĞ ǀĂƌŝĂŶƚƐ ƚŽ ĐŽŶƐŝĚĞƌ͘ ƐƐƵŵƉƟŽŶƐ ŽĨ Ă ƌĞĐĞƐƐŝǀĞ ŝŶŚĞƌŝƚĂŶĐĞ ŵŽĚĞů ĂŶĚ ƚŚĞ ĂƉƉůŝĐĂƟŽŶŽĨƐƚƌŝŶŐĞŶƚĮůƚĞƌƐ͕ƐƵĐŚĂƐĐŽŶƐŝĚĞƌĂƟŽŶŽĨŽŶůLJƐƚƌŽŶŐůLJĚĂŵĂŐŝŶŐ͕ůŽƐƐͲŽĨͲ ĨƵŶĐƟŽŶ;>Ž&ͿǀĂƌŝĂŶƚƐ͕ŝƐŽŶĞƉŽƚĞŶƟĂůƐŽůƵƟŽŶ͕ďƵƚƚŚŝƐŝƐůŝŬĞůLJƚŽŵŝƐƐŵĂŶLJŝŵƉŽƌƚĂŶƚ ǀĂƌŝĂŶƚƐ͕ ŝŶĐůƵĚŝŶŐ ĚŽŵŝŶĂŶƚůLJͲĂĐƟŶŐ ĂůůĞůĞƐ͘ &ƵƌƚŚĞƌ͕ W ŝƐ ĐŚĂƌĂĐƚĞƌŝnjĞĚ ďLJ ĞdžƚĞŶƐŝǀĞ ŐĞŶŝĐĂŶĚĂůůĞůŝĐŚĞƚĞƌŽŐĞŶĞŝƚLJĂŶĚĞdžƚƌĞŵĞůLJůĂƌŐĞĐŽŚŽƌƚƐŵĂLJďĞƌĞƋƵŝƌĞĚƚŽĚŽĐƵŵĞŶƚ ƐƵĸĐŝĞŶƚŶƵŵďĞƌƐŽĨĐĂƐĞƐƚŽĨĂĐŝůŝƚĂƚĞŵĞĂŶŝŶŐĨƵůƐƚĂƟƐƟĐĂůĐŽŵƉĂƌŝƐŽŶƐ͘15 Lastly, as PD ŝƐ;ŝͿĐŽŵŵŽŶ;ΕϭͲϯйƉƌĞǀĂůĞŶĐĞͿ͕;ŝŝͿƐƚƌŽŶŐůLJĂŐĞͲĚĞƉĞŶĚĞŶƚ͕ĂŶĚ;ŝŝŝͿŽŌĞŶƉƌĞĐĞĚĞĚ ďLJ Ă ƉƌŽůŽŶŐĞĚ ƉƌĞƐLJŵƉƚŽŵĂƟĐ Žƌ ŵŝŶŝŵĂůůLJ ƐLJŵƉƚŽŵĂƟĐ ƉŚĂƐĞ͕ ǁĞ ŵĂLJ ĞdžƉĞĐƚ ƚŽ ĮŶĚ ƚƌƵůLJ ƉĂƚŚŽŐĞŶŝĐ ƌĂƌĞ ǀĂƌŝĂŶƚƐ͕ ŝŶĐůƵĚŝŶŐ ƚŚŽƐĞ ǁŝƚŚ ůĂƌŐĞ ĞīĞĐƚ ƐŝnjĞƐ͕ ŝŶ ͞ĐŽŶƚƌŽů͟ ĐŽŚŽƌƚƐŽĨĂĚƵůƚƐ;ĚƵĞƚŽƵŶƌĞĐŽŐŶŝnjĞĚŽƌĞĂƌůLJĚŝƐĞĂƐĞƐƚĂŐĞƐǁŝƚŚŵŝŶŝŵĂůƐLJŵƉƚŽŵƐͿ͘ dŚĞƌĞĨŽƌĞ͕ŐŝǀĞŶƚŚĞŽĐĐƵƌƌĞŶĐĞŽĨƌĂƌĞǀĂƌŝĂŶƚƐ͕ŝŶĐůƵĚŝŶŐƉŽƚĞŶƟĂůůLJĚĂŵĂŐŝŶŐǀĂƌŝĂŶƚƐ in most genomes of presumably healthy individuals,16ŝƚŵĂLJďĞĚŝĸĐƵůƚƚŽŝĚĞŶƟĨLJŐĞŶĞƐͬ

(6)

6

/Ŷ ƚŚŝƐ ĐŽůůĂďŽƌĂƟǀĞ ƐƚƵĚLJ ŽĨ ƚŚĞ /ŶƚĞƌŶĂƟŽŶĂů WĂƌŬŝŶƐŽŶ͛Ɛ ŝƐĞĂƐĞ 'ĞŶŽŵŝĐƐ ŽŶƐŽƌƟƵŵ;/W'Ϳ͕ǁĞƌĞƉŽƌƚƚŚĞƌĞƐƵůƚƐŽĨǁŚŽůĞĞdžŽŵĞƐĞƋƵĞŶĐŝŶŐ;t^ͿŝŶϭ͕ϭϰϴ WĐĂƐĞƐ͕ƚŚĞůĂƌŐĞƐƚƐƵĐŚĐŽŚŽƌƚĞdžĂŵŝŶĞĚƚŽĚĂƚĞ͘ŽŶƐŝƐƚĞŶƚǁŝƚŚƚŚĞLJŽƵŶŐĞƌĂŐĞŽĨ WŽŶƐĞƚŝŶƚŚŝƐĐŽŚŽƌƚ͕ǁŚŝĐŚŝƐŽŌĞŶĂƐƐŽĐŝĂƚĞĚǁŝƚŚĂƌĞĐĞƐƐŝǀĞŝŶŚĞƌŝƚĂŶĐĞ͕17-19 and to ƉƌŝŽƌŝƟnjĞĐĂŶĚŝĚĂƚĞŐĞŶĞƐͬǀĂƌŝĂŶƚƐĨŽƌŝŶŝƟĂůŝŶǀĞƐƟŐĂƟŽŶ͕ŽƵƌĂŶĂůLJƐŝƐĨŽĐƵƐĞƐŽŶŐĞŶĞƐ ǁŝƚŚŚŽŵŽnjLJŐŽƵƐŽƌĐŽŵƉŽƵŶĚŚĞƚĞƌŽnjLJŐŽƵƐ>Ž&ǀĂƌŝĂŶƚƐ͘tĞĨƵƌƚŚĞƌĐŽƵƉůĞƚŚĞŚƵŵĂŶ ŐĞŶĞƟĐ ƐƚƵĚŝĞƐ ǁŝƚŚ ĨƵŶĐƟŽŶĂů ƐĐƌĞĞŶŝŶŐ ŝŶ ŵĂŵŵĂůŝĂŶ ĐĞůů ĐƵůƚƵƌĞ ĂŶĚ ŝŶǀĞƌƚĞďƌĂƚĞ ĂŶŝŵĂůŵŽĚĞůƐ͕ƐƵĐĐĞƐƐĨƵůůLJŝĚĞŶƟĨLJŝŶŐƚŚŽƐĞĐĂŶĚŝĚĂƚĞŐĞŶĞƐƐŚŽǁŝŶŐŝŶƚĞƌĂĐƟŽŶƐǁŝƚŚ ĞƐƚĂďůŝƐŚĞĚWŵĞĐŚĂŶŝƐŵƐ͕ŝŶĐůƵĚŝŶŐŵŝƚŽĐŚŽŶĚƌŝĂůĚLJŶĂŵŝĐƐĂŶĚɲͲƐLJŶƵĐůĞŝŶŵĞĚŝĂƚĞĚ ŶĞƵƌŽĚĞŐĞŶĞƌĂƟŽŶ͘ůƚŚŽƵŐŚŶŽƐƵĸĐŝĞŶƚůLJƉŽǁĞƌĞĚĞdžŽŵĞĚĂƚĂƐĞƚǁĂƐĂǀĂŝůĂďůĞĨŽƌ ĚĞĮŶŝƟǀĞƌĞƉůŝĐĂƟŽŶ͕ŚƵŵĂŶŐĞŶĞƟĐǀĂůŝĚĂƟŽŶǁĂƐƵŶĚĞƌƚĂŬĞŶŝŶƐĞǀĞƌĂůŝŶĚĞƉĞŶĚĞŶƚ ĚĂƚĂƐĞƚƐ͘KƵƌŝŶƚĞŐƌĂƚĞĚĂƉƉƌŽĂĐŚŝĚĞŶƟĮĞƐĮǀĞƐƚƌŽŶŐĐĂŶĚŝĚĂƚĞWƐƵƐĐĞƉƟďŝůŝƚLJŐĞŶĞƐ ǁŽƌƚŚLJŽĨĨƵƌƚŚĞƌŝŶǀĞƐƟŐĂƟŽŶ͕ĂŶĚĞdžĞŵƉůŝĮĞƐĂƉŽǁĞƌĨƵůƐƚƌĂƚĞŐLJǁŝƚŚƉŽƚĞŶƟĂůďƌŽĂĚ applicability to the follow up of future rare variant studies in PD and other neurologic ĚŝƐŽƌĚĞƌƐǁŝƚŚĐŽŵƉůĞdžŐĞŶĞƟĐĞƟŽůŽŐŝĞƐ͘

Z^h>d^

ŝƐĐŽǀĞƌLJŽĨƌĞĐĞƐƐŝǀĞůŽƐƐͲŽĨͲĨƵŶĐƟŽŶǀĂƌŝĂŶƚƐĨƌŽŵWĞdžŽŵĞƐ

 ƚŽƚĂů ŽĨ ϵϮϬ͕ϴϵϲ ǀĂƌŝĂŶƚƐ ;ϵϯ͘Ϯй ƐŝŶŐůĞ ŶƵĐůĞŽƟĚĞ ǀĂƌŝĂŶƚƐ ĂŶĚ ϲ͘ϴй ŝŶƐĞƌƟŽŶƐ ĂŶĚ ĚĞůĞƟŽŶƐͿǁĞƌĞĐĂůůĞĚŝŶĂt^ĚĂƚĂƐĞƚŽĨϭ͕ϲϱϭƐƵďũĞĐƚƐ͕ŝŶĐůƵĚŝŶŐϭ͕ϭϰϴLJŽƵŶŐͲŽŶƐĞƚ PD cases (average age of onset 40.6 years, range 5-56 years) and 503 control subjects with European ancestry. As our cohort has an average age at onset below 45 years, ǁĞĨŽĐƵƐĞĚŽƵƌƐĞĂƌĐŚŽŶŚŽŵŽnjLJŐŽƵƐĂŶĚƉƵƚĂƟǀĞĐŽŵƉŽƵŶĚŚĞƚĞƌŽnjLJŐŽƵƐǀĂƌŝĂŶƚƐ͕ consistent with a recessive inheritance model. Although most PD cases were prescreened ĨŽƌŵƵƚĂƟŽŶƐŝŶĞƐƚĂďůŝƐŚĞĚWŐĞŶĞƐ͕ǁĞŝĚĞŶƟĮĞĚϮƐƵďũĞĐƚƐǁŝƚŚŚŽŵŽnjLJŐŽƵƐĞdžŽŶŝĐ variants in parkin and PINK1 ;^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϭͿ͘/ŶŽƌĚĞƌƚŽŝĚĞŶƟĨLJŶŽǀĞůWŐĞŶĞ ĐĂŶĚŝĚĂƚĞƐ ǁĞ ĨŽĐƵƐĞĚ ŽŶ ǀĂƌŝĂŶƚƐ ƚŚĂƚ ĂƌĞ ƌĂƌĞ ŝŶ ĐŽŶƚƌŽů ƉŽƉƵůĂƟŽŶƐ͘ ŽŶƐŝĚĞƌŝŶŐ the worldwide prevalence for PD (0.041% in individuals aged 40-49 years),20 we used a

(7)

6

ŐŐƌĞŐĂƟŽŶŽŶƐŽƌƟƵŵ;džͿͿĂŶĚƚŚĞƌĞĨŽƌĞŝŵƉůŝĐĂƚĞĚƚŽďĞŶŽǀĞů͘džĐĞƉƚŝŶƚŚĞĐĂƐĞ of ARSB͕ƚŚĞϮϲŽƚŚĞƌŐĞŶĞƐŚĂƌďŽƌ>Ž&ǀĂƌŝĂŶƚƐŝŶŽŶůLJĂƐŝŶŐůĞĐĂƐĞ͕ĐŽŶƐŝƐƚĞŶƚǁŝƚŚƚŚĞ ŚLJƉŽƚŚĞƐŝƐƚŚĂƚŶŽǀĞůƌĞĐĞƐƐŝǀĞWĂůůĞůĞƐŵĂLJĐŽŶƐŝƐƚŽĨŵĂŶLJƌĂƌĞ͕͞ƉƌŝǀĂƚĞ͟ŵƵƚĂƟŽŶƐ͘ &ŽƵƌWĐĂƐĞƐŝŶŽƵƌĐŽŚŽƌƚǁĞƌĞŝĚĞŶƟĮĞĚǁŝƚŚĂ>Ž&ǀĂƌŝĂŶƚŝŶƚŚĞARSB gene, in which ŵƵƚĂƟŽŶƐŚĂǀĞƉƌĞǀŝŽƵƐůLJďĞĞŶůŝŶŬĞĚǁŝƚŚƚŚĞƌĞĐĞƐƐŝǀĞůLJƐŽƐŽŵĂůƐƚŽƌĂŐĞĚŝƐŽƌĚĞƌ͕DW^ s/;ĂůƐŽĐĂůůĞĚDĂƌŽƚĞĂƵdžͲ>ĂŵLJ^LJŶĚƌŽŵĞͿ͘ůůϰŝŶĚŝǀŝĚƵĂůĐĂƐĞƐ͕ĂůŽŶŐǁŝƚŚϭĐŽŶƚƌŽů ƐƵďũĞĐƚ͕ ǁĞƌĞ ŚŽŵŽnjLJŐŽƵƐ ĨŽƌ Ă ǀĂƌŝĂŶƚ ;ƌƐϭϯϴϮϳϵϬϮϬͿ ƉƌĞĚŝĐƚĞĚ ƚŽ ĚŝƐƌƵƉƚ ƐƉůŝĐŝŶŐ͘ High-quality calls: 920,896 variants Autosomal exonic: 446,139 variants D&чϭй͗ 386,078 variants Loss-of-Function: 5,906 variants Homozygous freq. cases > controls: 18 genes Case-specific putative CH: 9 genes Stop codon: 17 genes Splicing: 1 gene LoF + miss: 3 genes 2x LoF: 6 genes C St Annotation RefSeq & UCSC

Annotation 1000G, ESP6500 & ExAC

Manual curation IGV Count with KGGSeq

(8)
(9)
(10)

6

ůƚŚŽƵŐŚƚŚŝƐǀĂƌŝĂŶƚŝƐŶĞŝƚŚĞƌƌĞƉŽƌƚĞĚŝŶdžŶŽƌǁĂƐĨƌĞƋƵĞŶĐLJŝŶĨŽƌŵĂƟŽŶĂǀĂŝůĂďůĞ ĨƌŽŵ Ěď^EW͕ ƚŚĞ D& ǁĂƐ Ϭ͘Ϭϲϱ ŝŶ ŽƵƌ ĐŽŚŽƌƚ ;D&CASESсϬ͘Ϭϳϯ͕ D&KEdZK>^=0.052,

pсϬ͘ϬϱϰͿ͘ůƚŚŽƵŐŚƌĞůĂƟǀĞůLJĨƌĞƋƵĞŶƚŝŶŽƵƌĐŽŶƚƌŽůĚĂƚĂƐĞƚ;D&хϭйͿ͕ǁĞŚĂǀĞƌĞƚĂŝŶĞĚ ŝƚ ĂŵŽŶŐ ŽƵƌ ƌĞƐƵůƚƐ͕ ďĂƐĞĚ ŽŶ ϯ ĐŽŶƐŝĚĞƌĂƟŽŶƐ͘ &ŝƌƐƚ͕ ŝŶĨŽƌŵĂƟŽŶ ǁĂƐ ŶŽƚ ƉƌĞƐĞŶƚ ŝŶ Ěď^EW͕džŽƌ^WϲϱϬϬ͕ǁŚŝĐŚǁĂƐƚŚĞďĂƐŝƐĨŽƌĂƉƉůLJŝŶŐƚŚŝƐĨƌĞƋƵĞŶĐLJĮůƚĞƌŝŶĂůůŽƚŚĞƌ ĐĂƐĞƐ͘ ^ĞĐŽŶĚ͕ Ăƚ ůĞĂƐƚ ŽŶĞ ŽĨ ƚŚĞ ŚŽŵŽnjLJŐŽƵƐ ŝŶĚŝǀŝĚƵĂůƐ ŚĂĚ ĐůŝŶŝĐĂů ŵĂŶŝĨĞƐƚĂƟŽŶƐ ĐŽŶƐŝƐƚĞŶƚǁŝƚŚDW^s/͕ƐƵƉƉŽƌƟŶŐƉŽƚĞŶƟĂůƉĂƚŚŽŐĞŶŝĐŝƚLJŽĨƚŚŝƐĂůůĞůĞ;ƐĞĞŝƐĐƵƐƐŝŽŶͿ͘ >ĂƐƚůLJ͕ĂƐĚĞƚĂŝůĞĚďĞůŽǁ͕ŽƵƌĨƵŶĐƟŽŶĂůƐƚƵĚŝĞƐŝĚĞŶƟĨLJůŝŶŬƐďĞƚǁĞĞŶŵĂŶŝƉƵůĂƟŽŶŽĨ Z^ĂŶĚĐĞůůƵůĂƌͬŽƌŐĂŶŝƐŵĂůƉŚĞŶŽƚLJƉĞƐĐŽŶƐŝƐƚĞŶƚǁŝƚŚĂƉŽƚĞŶƟĂůƌŽůĞŝŶW͘ KĨ ŶŽƚĞ͕ ǁŚŝůĞ ƚŚĞ ĂŶĂůLJƐĞƐ ŽĨ ƚŚĞ /W' t^ ĚĂƚĂƐĞƚ ĂŶĚ ƐƵďƐĞƋƵĞŶƚ ǁŽƌŬ ĚĞƐĐƌŝďĞĚŚĞƌĞǁĞƌĞŝŶƉƌŽŐƌĞƐƐ͕ĂŶŝŶĚĞƉĞŶĚĞŶƚĨĂŵŝůLJͲďĂƐĞĚƐĞƋƵĞŶĐŝŶŐƐƚƵĚLJŝĚĞŶƟĮĞĚ

VPS13C as a cause of autosomal recessive parkinsonism.21 ůƚŚŽƵŐŚ ƚŚĞ ƐŝŶŐůĞ /W'

ƐƵďũĞĐƚ ǁŝƚŚ ĐŽŵƉŽƵŶĚ ŚĞƚĞƌŽnjLJŐŽƵƐ VPS13C >Ž& ĂůůĞůĞƐ ǁĂƐ ƉƵďůŝƐŚĞĚ ĂƐ Ă ƌĞƉůŝĐĂƚĞ case in that work, we retained it among the 27 candidates described here, since it was independently carried forward for all analyses detailed below.

dŽůĞƌĂďŝůŝƚLJŽĨŐĞŶĞůŽƐƐͲŽĨͲĨƵŶĐƟŽŶŝŶŚƵŵĂŶƐĂŶĚĂŶŝŵĂůŵŽĚĞůƐ dŚĞ͞ƚŽůĞƌĂďŝůŝƚLJ͟ŽĨƌĞĐĞƐƐŝǀĞ>Ž&ŐĞŶŽƚLJƉĞƐŚĂƐŝŵƉŽƌƚĂŶƚŝŵƉůŝĐĂƟŽŶƐĨŽƌƵŶĚĞƌƐƚĂŶĚŝŶŐ ƚŚĞ ŐĞŶĞƟĐ ďĂƐŝƐ ŽĨ ĂĚƵůƚͲŽŶƐĞƚ͕ ĂŐĞͲŝŶŇƵĞŶĐĞĚ ĚŝƐŽƌĚĞƌƐ ƐƵĐŚ ĂƐ W͘ Ɛ ŵŽƐƚ ŽĨ ƚŚĞ ŝĚĞŶƟĮĞĚŚŽŵŽnjLJŐŽƵƐĂŶĚƉƵƚĂƟǀĞĐŽŵƉŽƵŶĚŚĞƚĞƌŽnjLJŐŽƵƐ>Ž&ŐĞŶŽƚLJƉĞƐĂƌĞďĂƐĞĚŽŶ ĂƐŝŶŐůĞŝŶĚŝǀŝĚƵĂů͕ǁĞĂůƐŽĞdžĂŵŝŶĞĚĨŽƌƚŚĞŝƌŽĐĐƵƌƌĞŶĐĞŝŶĂůĂƌŐĞ͕ƌĞĐĞŶƚůLJƉƵďůŝƐŚĞĚ study16 ŽĨ ƉƌĞĚŝĐƚĞĚ ĐŽŵƉůĞƚĞ ŐĞŶĞ ŬŶŽĐŬͲŽƵƚƐ ŝŶ ƚŚĞ /ĐĞůĂŶĚŝĐ ƉŽƉƵůĂƟŽŶ͕ ŝŶĐůƵĚŝŶŐ

104,220 subjects with imputed genotypes, based on whole genome sequencing from a ƐƵďƐĞƚŽĨϮ͕ϯϲϯŝŶĚŝǀŝĚƵĂůƐ͘dŚĞ/ĐĞůĂŶĚŝĐƉŽƉƵůĂƟŽŶŝƐĞŶƌŝĐŚĞĚĨŽƌƌĂƌĞĚŝƐĞĂƐĞͲĐĂƵƐŝŶŐ ŵƵƚĂƟŽŶƐǁŝƚŚĂƌĞĐĞƐƐŝǀĞŝŶŚĞƌŝƚĂŶĐĞƉĂƩĞƌŶ͕ŐŝǀĞŶĂƐƚƌŽŶŐĨŽƵŶĚĞƌĞīĞĐƚĂŶĚŶŽŶͲ ƌĂŶĚŽŵŵĂƟŶŐƉĂƩĞƌŶƐ͘dǁĞůǀĞŽĨƚŚĞǀĂƌŝĂŶƚƐƚŚĂƚǁĞŝĚĞŶƟĮĞĚĂƌĞĂůƐŽƉƌĞƐĞŶƚŝŶƚŚĞ /ĐĞůĂŶĚŝĐƐƚƵĚLJ;^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϮͿ͖ŚŽǁĞǀĞƌ͕ƚŚĞŽďƐĞƌǀĞĚŚŽŵŽnjLJŐŽƚĞĨƌĞƋƵĞŶĐŝĞƐ ĂƌĞŶŽƚƐƵĸĐŝĞŶƚůLJŚŝŐŚƚŽĐŽŶĮĚĞŶƚůLJĞdžĐůƵĚĞƚŚĞŵĂƐƉŽƐƐŝďůĞWŐĞŶĞƐĂŶĚŝŵƉŽƌƚĂŶƚůLJ͕ ĚĞƚĂŝůĞĚƉŚĞŶŽƚLJƉŝĐĚĂƚĂŝƐŶŽƚƉƵďůŝĐĂůůLJĂǀĂŝůĂďůĞĨŽƌƚŚĞƐĞƐƵďũĞĐƚƐ͘&ŽƌĞdžĂŵƉůĞ͕Ϯϵ /ĐĞůĂŶĚŝĐ ƐƵďũĞĐƚƐ ĂƌĞ ƌĞƉŽƌƚĞĚ ŚŽŵŽnjLJŐŽƵƐ ĨŽƌ ƚŚĞ ŝĚĞŶƟĐĂů PTCHD3 stopgain variant ;Đ͘ϭϰϮϲd͕Ɖ͘ZϰϳϲyͿĂƐƚŚĞƐŝŶŐůĞWĐĂƐĞŝŶŽƵƌt^ƐƚƵĚLJ͘,ŽǁĞǀĞƌ͕ƚŚŝƐŝƐŽŶůLJϬ͘ϬϮϴй of the total sample set and below the reported prevalence of young-onset PD (0.041%).

tĞĂĚĚŝƟŽŶĂůůLJĞdžĂŵŝŶĞĚĨŽƌƚŚĞƉƌĞƐĞŶĐĞŽĨŽƚŚĞƌ>Ž&ǀĂƌŝĂŶƚƐǁŝƚŚĂƌĞĐĞƐƐŝǀĞ ŝŶŚĞƌŝƚĂŶĐĞ ƉĂƩĞƌŶ ŝŶ ŽƵƌ ŝŵƉůŝĐĂƚĞĚ ĐĂŶĚŝĚĂƚĞ ŐĞŶĞƐ ;^ƵƉƉůĞŵĞŶƚĂƌLJ dĂďůĞ ϮͿ͘ &Žƌ Ă ƐƵďƐĞƚŽĨŐĞŶĞƐ͕ǁĞŝŶĚĞĞĚŝĚĞŶƟĮĞĚƐĞǀĞƌĂůǀĂƌŝĂŶƚƐǁŝƚŚƉĂƌƟĐƵůĂƌůLJŚŝŐŚŚŽŵŽnjLJŐŽƚĞ frequencies including OR7G3 (9.16%), SSPO (9.38%) and PTCHD3 (16.55%). This is ĐŽŶƐŝƐƚĞŶƚ ǁŝƚŚ ƉƌŝŽƌ ƌĞƉŽƌƚƐ ĚĞƐĐƌŝďŝŶŐ Ă ŚŽŵŽnjLJŐŽƵƐ ĚĞůĞƟŽŶ ĐŽǀĞƌŝŶŐ PTCHD3 in ĂƉƉĂƌĞŶƚůLJŚĞĂůƚŚLJŝŶĚŝǀŝĚƵĂůƐ͕ĐŽŶƐŝƐƚĞŶƚǁŝƚŚĂŶŽŶͲĞƐƐĞŶƟĂůƌŽůĞ͘22 Assuming that the

(11)

6

WES data, their high variant frequency makes these genes unlikely to be highly penetrant PD risk loci. ,ƵŵĂŶŐĞŶĞƐŚĂƌďŽƌŝŶŐŚŽŵŽnjLJŐŽƵƐ>Ž&ǀĂƌŝĂŶƚƐͶĞƐƉĞĐŝĂůůLJƚŚŽƐĞŽďƐĞƌǀĞĚ ƌĞĐƵƌƌĞŶƚůLJ ŝŶ ůĂƌŐĞ ƉŽƉƵůĂƟŽŶͲďĂƐĞĚ ĚĂƚĂƐĞƚƐ͕ ƉŽƚĞŶƟĂůůLJ ŝĚĞŶƟĨLJ ŐĞŶĞƐ ƚŚĂƚ ĂƌĞ ĚŝƐƉĞŶƐĂďůĞ ĨŽƌ ĨĞƚĂů ĂŶĚ ƐƵďƐĞƋƵĞŶƚ ĐŚŝůĚ ĚĞǀĞůŽƉŵĞŶƚ͘ 'ŝǀĞŶ ƚŚĞ ůŝŵŝƚĞĚ ŚƵŵĂŶ ƉŚĞŶŽƚLJƉŝĐŝŶĨŽƌŵĂƟŽŶĂǀĂŝůĂďůĞ͕ǁĞĨƵƌƚŚĞƌŝŶǀĞƐƟŐĂƚĞĚƚŚĞƉŽƚĞŶƟĂůƚŽůĞƌĂďŝůŝƚLJĨŽƌƚŚĞ ŝŵƉůŝĐĂƚĞĚŐĞŶĞƐƵƐŝŶŐĂĐƌŽƐƐͲƐƉĞĐŝĞƐĂƉƉƌŽĂĐŚ͕ƉĞƌĨŽƌŵŝŶŐƐLJƐƚĞŵĂƟĐ>Ž&ĂŶĂůLJƐŝƐŝŶ the nematode, C. elegans. KƵƚŽĨƚŚĞϮϳĐĂŶĚŝĚĂƚĞŐĞŶĞƐŝĚĞŶƟĮĞĚŝŶŽƵƌt^ĂŶĂůLJƐŝƐ͕ 10 were well conserved in the C. elegans ŐĞŶŽŵĞ͕ ĂŶĚ ϵ ŚĂĚ ƌĞĂĚŝůLJ ĂǀĂŝůĂďůĞ ZEͲ ŝŶƚĞƌĨĞƌĞŶĐĞ;ZEŝͿƌĞĂŐĞŶƚƐĨŽƌ>Ž&ƐĐƌĞĞŶŝŶŐ;ƐĞĞDĞƚŚŽĚƐͿ͘ĂĐŚŐĞŶĞǁĂƐƚĂƌŐĞƚĞĚ ĨŽƌŬŶŽĐŬĚŽǁŶƵƐŝŶŐZEŝĂŶĚǁĞĂƐƐĞƐƐĞĚĨŽƌĚĞǀĞůŽƉŵĞŶƚĂůůĞƚŚĂůŝƚLJĂŶĚƐƵƌǀŝǀĂů͘dŚĞ ƌĞƐƵůƚƐŽĨƚŚĞƐĞƐƚƵĚŝĞƐ͕ĂůŽŶŐǁŝƚŚŽƚŚĞƌ>Ž&ĚĂƚĂĨƌŽŵƉƵďůŝĐĚĂƚĂďĂƐĞƐ͕ĂƌĞĂǀĂŝůĂďůĞ ŝŶ^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϯ͘<ŶŽĐŬĚŽǁŶŽĨŚŽŵŽůŽŐƐŽĨDIS3 (ĚŝƐͲϯ), KALRN (unc-73), and

PTCHD3 (ptr-10) resulted in developmental arrest and/or reduced survival in C. elegans.

Notably, homologs of KALRN and DIS3 are also associated with reduced viability following ŐĞŶĞƟĐĚŝƐƌƵƉƟŽŶŝŶďŽƚŚDrosophila23,24 and mice.25, 26dŚƵƐ͕ƚŚĞƐĞƌĞƐƵůƚƐĂƌĞƉŽƚĞŶƟĂůůLJ

ĐŽŶƐŝƐƚĞŶƚǁŝƚŚĐŽŶƐĞƌǀĞĚ͕ĞĂƌůLJĂŶĚͬŽƌĞƐƐĞŶƟĂůĚĞǀĞůŽƉŵĞŶƚĂůƌŽůĞƐĨŽƌƚŚĞƐĞŐĞŶĞƐĂŶĚ ƚŚĞĂďƐĞŶĐĞŽĨŝŶĚŝǀŝĚƵĂůƐŚĂƌďŽƌŝŶŐŚŽŵŽnjLJŐŽƵƐ>Ž&ǀĂƌŝĂŶƚƐŝŶƚŚĞ/ĐĞůĂŶĚŝĐĐŽŚŽƌƚ͘16 ^ŝŶĐĞƚŚĞŚƵŵĂŶŐĞŶŽŵĞĐŽŶƚĂŝŶƐŵƵůƟƉůĞŐĞŶĞƉĂƌĂůŽŐƐĨŽƌKALRN and PTCHD3, ŐĞŶĞƟĐƌĞĚƵŶĚĂŶĐLJŵŝŐŚƚĂĐĐŽƵŶƚĨŽƌŚŽǁ>Ž&ŵŝŐŚƚďĞƚŽůĞƌĂƚĞĚŝŶŚƵŵĂŶƐďƵƚŶŽƚ ŝŶƐŝŵƉůĞĂŶŝŵĂůŵŽĚĞůƐ͘ůƚĞƌŶĂƟǀĞůLJ͕ŝƚŝƐƉŽƐƐŝďůĞƚŚĂƚƚŚĞĂůůĞůŝĐǀĂƌŝĂŶƚƐŝŵƉůŝĐĂƚĞĚ ŝŶŽƵƌWt^ĐŽŚŽƌƚĂŶĚ/ĐĞůĂŶĚŝĐƐƚƵĚLJŵŝŐŚƚŶŽƚĐĂƵƐĞĂĐŽŵƉůĞƚĞ>Ž&;i.e.ŐĞŶĞƟĐ ŶƵůůͿĚĞƐƉŝƚĞƚŚĞĂůŐŽƌŝƚŚŵŝĐƉƌĞĚŝĐƟŽŶƐ͕ŝŶƐƚĞĂĚĐĂƵƐŝŶŐŽŶůLJĂƉĂƌƟĂůůŽƐƐͲŽĨͲĨƵŶĐƟŽŶ͘ EĞǀĞƌƚŚĞůĞƐƐ͕ƚŚĞƐĞĐƌŽƐƐͲƐƉĞĐŝĞƐĐŽŵƉĂƌŝƐŽŶƐƐƵŐŐĞƐƚĞƐƐĞŶƟĂůĂŶĚĞĂƌůLJĚĞǀĞůŽƉŵĞŶƚĂů roles for homologs of PTCHD3, DIS3 and KALRN, and ŝŶĨŽƌŵŝŶŐ ŽƵƌ ĐŽŶƐŝĚĞƌĂƟŽŶ ŽĨ ƉŽƚĞŶƟĂůĐŽŶƚƌŝďƵƟŽŶƚŽĂĚƵůƚͲŽŶƐĞƚĚŝƐŽƌĚĞƌƐ͕ƐƵĐŚĂƐW͘

sĂƌŝĂŶƚĂŐŐƌĞŐĂƟŽŶĂŶĂůLJƐĞƐ

(12)

6

KƵƌ ĂŶĂůLJƐĞƐ ŽĨ >Ž& ǀĂƌŝĂŶƚƐ ŝŶ W ĞdžŽŵĞƐ ŝĚĞŶƟĨLJ Ă ŶƵŵďĞƌ ŽĨ ƉƌŽŵŝƐŝŶŐ ĐĂŶĚŝĚĂƚĞŐĞŶĞƐ͘,ŽǁĞǀĞƌ͕ĞǀĞŶƚŚŽƵŐŚĂƉŽƐŝƟǀĞĨĂŵŝůLJŚŝƐƚŽƌLJǁĂƐŽďƐĞƌǀĞĚĨŽƌĂůŵŽƐƚ ϰϬйŽĨƚŚĞĐĂƐĞƐ͕ƐĞŐƌĞŐĂƟŽŶĂŶĂůLJƐŝƐŽĨƚŚĞǀĂƌŝĂŶƚƐŝŶĨĂŵŝůŝĞƐŝƐŶŽƚĨĞĂƐŝďůĞ͕ĂƐE ƐĂŵƉůĞƐ ĂƌĞ ŶŽƚ ĂǀĂŝůĂďůĞ ĨƌŽŵ ĂĚĚŝƟŽŶĂů ĨĂŵŝůLJ ŵĞŵďĞƌƐ͘ &ƵƌƚŚĞƌ͕ ƐŝŶĐĞ ŵŽƐƚ ŽĨ ƚŚĞ genes implicated contribute to single or few cases, we are unable to perform meaningful ƐƚĂƟƐƟĐĂůĐŽŵƉĂƌŝƐŽŶƐ͕ďĂƐĞĚŽŶƚŚĞůŝŵŝƚĞĚŶƵŵďĞƌƐŽĨ>Ž&ǀĂƌŝĂŶƚƐŝĚĞŶƟĮĞĚďLJt^ ŝŶĐĂƐĞƐǀƐ͘ĐŽŶƚƌŽůƐ͘ƐĂŶĂůƚĞƌŶĂƟǀĞƐƚƌĂƚĞŐLJǁĞƚŚĞƌĞĨŽƌĞĚĞƉůŽLJĞĚĂĐŽŵďŝŶĂƟŽŶŽĨ ĐĞůůͲďĂƐĞĚĂŶĚŵŽĚĞůŽƌŐĂŶŝƐŵĨƵŶĐƟŽŶĂůƐĐƌĞĞŶƐƚŽĚĞĮŶĞƉŽƚĞŶƟĂůůŝŶŬƐďĞƚǁĞĞŶƚŚĞ ϮϳĐĂŶĚŝĚĂƚĞŐĞŶĞƐ;dĂďůĞϭͿĂŶĚǁĞůůͲĞƐƚĂďůŝƐŚĞĚŵĞĐŚĂŶŝƐŵƐŽĨWƐƵƐĐĞƉƟďŝůŝƚLJĂŶĚ ƉĂƚŚŽŐĞŶĞƐŝƐ͕ŝŶĐůƵĚŝŶŐ;ϭͿŵŝƚŽĐŚŽŶĚƌŝĂůŚĞĂůƚŚĂŶĚ;ϮͿɲͲƐLJŶƵĐůĞŝŶŵĞĚŝĂƚĞĚƚŽdžŝĐŝƚLJ͘ &ƵŶĐƟŽŶĂůƉƌŝŽƌŝƟnjĂƟŽŶ͗ŵŝƚŽĐŚŽŶĚƌŝĂůŚĞĂůƚŚ ůƚŚŽƵŐŚ ƚŚĞ ŵĞĐŚĂŶŝƐŵ ŽĨ ŶĞƵƌŽĚĞŐĞŶĞƌĂƟŽŶ ŝŶ W ƌĞŵĂŝŶƐ ŝŶĐŽŵƉůĞƚĞůLJ ĚĞĮŶĞĚ ĂŶĚ ŵĂLJ ďĞ ŚĞƚĞƌŽŐĞŶĞŽƵƐ͕ ŵŝƚŽĐŚŽŶĚƌŝĂů ĚLJƐĨƵŶĐƟŽŶ ŚĂƐ ďĞĞŶ ƉƌŽƉŽƐĞĚ ƚŽ ƉůĂLJ ĂŶ ŝŵƉŽƌƚĂŶƚ ƌŽůĞ ƉĂƌƟĐƵůĂƌůLJ ŝŶ LJŽƵŶŐ ŽŶƐĞƚ W͘27-29 Notably, ƉĂƌŬŝŶ ;WZ<ϮͿ͕ :Ͳϭ and PINK1, associated with autosomal recessive, juvenile-onset Parkinsonism, have roles in

mitochondrial dynamics and quality control.30^ƉĞĐŝĮĐĂůůLJ͕WĂƌŬŝŶŝƐĂŶϯƵďŝƋƵŝƟŶůŝŐĂƐĞ

ĂŶĚƌĞĐƌƵŝƚĞĚƐĞůĞĐƟǀĞůLJƚŽĚLJƐĨƵŶĐƟŽŶĂůŵŝƚŽĐŚŽŶĚƌŝĂǁŝƚŚĂůŽǁŵĞŵďƌĂŶĞƉŽƚĞŶƟĂů͘31

&ƵƌƚŚĞƌ͕ƚŚĞŶĞƵƌŽƚŽdžŝĐŝƚLJŽĨɲͲƐLJŶƵĐůĞŝŶ͕ƚŚĞƉƌŝŵĂƌLJĐŽŶƐƟƚƵĞŶƚŽĨ>ĞǁLJďŽĚLJŝŶĐůƵƐŝŽŶƐ in PD, has also been linked to mitochondrial injury.32 tĞ ƚŚĞƌĞĨŽƌĞ ŚLJƉŽƚŚĞƐŝnjĞĚ ƚŚĂƚ

>Ž& ŝŶ ĐĂŶĚŝĚĂƚĞ ŐĞŶĞƐ ŝĚĞŶƟĮĞĚ ĨƌŽŵ ŽƵƌ ĂŶĂůLJƐĞƐ ŽĨ t^͕ ŵŝŐŚƚ ƐŝŵŝůĂƌůLJ ŝŵƉĂĐƚ ŵŝƚŽĐŚŽŶĚƌŝĂ͕ĐŽŶƐŝƐƚĞŶƚǁŝƚŚƌŽůĞƐŝŶWƐƵƐĐĞƉƟďŝůŝƚLJ͘

dŚĞƌĞĨŽƌĞ ǁĞ ƋƵĂŶƟĮĞĚ ŵŝƚŽĐŚŽŶĚƌŝĂů ŵŽƌƉŚŽůŽŐLJ ĂŌĞƌ ŐĞŶĞ ŬŶŽĐŬĚŽǁŶ ŝŶ ;ϮͿͲDϭϳ ŶĞƵƌŽďůĂƐƚŽŵĂ ĐĞůůƐ ďLJ ĞdžĂŵŝŶŝŶŐ ϯ ƉĂƌĂŵĞƚĞƌƐ ĐŽŵŵŽŶůLJ ƵƐĞĚ ĨŽƌ ƋƵĂŶƟĮĐĂƟŽŶ ŽĨ ŵŝƚŽĐŚŽŶĚƌŝĂů ŵŽƌƉŚŽůŽŐLJ͗ ŵŝƚŽĐŚŽŶĚƌŝĂů ŶƵŵďĞƌ͕ ĂdžŝĂů ůĞŶŐƚŚ ƌĂƟŽ͕ and roundness.33ĞůůƐƚƌĂŶƐĚƵĐĞĚǁŝƚŚƚŚĞƐŚZEĞŶĐŽĚŝŶŐĂƐĐƌĂŵďůĞĚƐĞƋƵĞŶĐĞǁĞƌĞ

ƵƐĞĚĨŽƌŶŽƌŵĂůŝnjĂƟŽŶĂŶĚƉŽƐŝƟǀĞĐŽŶƚƌŽůƐĨŽƌŵŝƚŽĐŚŽŶĚƌŝĂůŵŽƌƉŚŽůŽŐLJǁĞƌĞŝŶĐůƵĚĞĚ ŝŶĞĂĐŚĞdžƉĞƌŝŵĞŶƚ͘&ŽƌĞdžĂŵƉůĞ͕ŬŶŽĐŬĚŽǁŶŽĨƚŚĞŵŝƚŽĐŚŽŶĚƌŝĂůĮƐƐŝŽŶŐĞŶĞĚLJŶĂŵŝŶ 1-like (DNM1LͿ͕ Ă ƉŽƐŝƟǀĞ ĐŽŶƚƌŽů͕ ƌĞƐƵůƚƐ ŝŶ ĞůŽŶŐĂƚĞĚ ŵŝƚŽĐŚŽŶĚƌŝĂ ĂŶĚ ƚŚĞƌĞĨŽƌĞ ĚĞĐƌĞĂƐĞƐŵŝƚŽĐŚŽŶĚƌŝĂůĂdžŝĂůůĞŶŐƚŚƌĂƟŽĂŶĚƌŽƵŶĚŶĞƐƐ;&ŝŐƵƌĞϮ͕Ϳ͘34<ŶŽĐŬĚŽǁŶŽĨ

ϭϯŐĞŶĞƐƐŚŽǁĂƐŝŐŶŝĮĐĂŶƚĞīĞĐƚŽŶĂƚůĞĂƐƚŽŶĞŽĨƚŚĞϯƉĂƌĂŵĞƚĞƌƐ;^ƵƉƉůĞŵĞŶƚĂƌLJ dĂďůĞϱ͖^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϭͿ͘GPATCH2L shows the largest increase in mitochondrial roundness, while h,Z&ϭWϭ>ĚŝƐƉůĂLJƐƚŚĞůĂƌŐĞƐƚĚĞĐƌĞĂƐĞ;&ŝŐƵƌĞϮ͕Ϳ͘

(13)

6

A C D B Scr transduced DNM1L shRNA

Scr transduced UHRF1BP1L shRNA

(14)

6

A

C

D B

Figure 3. ,ŝŐŚ ĐŽŶƚĞŶƚ ĂƐƐĂLJ ĨŽƌ WĂƌŬŝŶ dƌĂŶƐůŽĐĂƟŽŶ͘ īĞĐƚ ŽĨ W/E<ϭ ƐŚZE ; ĂŶĚ Ϳ ĂŶĚ

(15)

6

ŽƵƌĂƐƐĂLJ͘WͲŝŶĚƵĐĞĚWĂƌŬŝŶĂĐĐƵŵƵůĂƟŽŶǁĂƐĂƐƐĞƐƐĞĚďLJŚŝŐŚͲĐŽŶƚĞŶƚŵŝĐƌŽƐĐŽƉLJ ĂŶĚĂƵƚŽŵĂƚĞĚŝŵĂŐĞĂŶĂůLJƐŝƐĨŽůůŽǁŝŶŐƐLJƐƚĞŵĂƟĐƐŚZEͲŬŶŽĐŬĚŽǁŶŽĨŽƵƌϮϳĐĂŶĚŝĚĂƚĞ ŐĞŶĞƐ;&ŝŐƵƌĞϯͿ͘ĂƐĞĚŽŶƐƚƌŝŶŐĞŶƚĐƌŝƚĞƌŝĂ;ƐĞĞDĞƚŚŽĚƐͿ͕ϲŐĞŶĞƐƐŝŐŶŝĮĐĂŶƚůLJŵŽĚŝĮĞĚ WĂƌŬŝŶƚƌĂŶƐůŽĐĂƟŽŶ;&ŝŐƵƌĞϯĂŶĚϯ͖^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϮ͖^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϱͿ͕ including 4 genes (GPATCH2L, PTCHD3, SVOPL and E&ϱϰϯͿǁŝƚŚĐŽŶƐŝƐƚĞŶƚĂĐƟǀŝƟĞƐŝŶ ďŽƚŚƚŚĞŵŝƚŽĐŚŽŶĚƌŝĂůŵŽƌƉŚŽůŽŐLJĂŶĚWĂƌŬŝŶƚƌĂŶƐůŽĐĂƟŽŶĂƐƐĂLJƐ͘ &ƵŶĐƟŽŶĂůƉƌŝŽƌŝƟnjĂƟŽŶ͗ɲͲ^LJŶƵĐůĞŝŶŵĞĚŝĂƚĞĚƚŽdžŝĐŝƚLJ  ǁĞĂůƚŚ ŽĨ ĞǀŝĚĞŶĐĞ ĂůƐŽ ƐƵƉƉŽƌƚƐ Ă ĐĞŶƚƌĂů ƌŽůĞ ĨŽƌ ɲͲƐLJŶƵĐůĞŝŶͲŵĞĚŝĂƚĞĚ ƚŽdžŝĐŝƚLJ ŝŶ WƉĂƚŚŽŐĞŶĞƐŝƐ͘ɲͲƐLJŶƵĐůĞŝŶĂŐŐƌĞŐĂƚĞƐ͕ƚĞƌŵĞĚ>ĞǁLJďŽĚŝĞƐ͕ĂƌĞƚŚĞĚĞĮŶŝŶŐĚŝƐĞĂƐĞ ƉĂƚŚŽůŽŐLJ͕ĂŶĚďŽƚŚɲͲƐLJŶƵĐůĞŝŶŐĞŶĞ;SNCAͿŵƵƚĂƟŽŶƐ͕ůŽĐƵƐŵƵůƟƉůŝĐĂƟŽŶ͕ĂŶĚƉƌŽŵŽƚĞƌ ƉŽůLJŵŽƌƉŚŝƐŵƐĂƌĞĂƐƐŽĐŝĂƚĞĚǁŝƚŚWƐƵƐĐĞƉƟďŝůŝƚLJ͘5&ƵƌƚŚĞƌ͕ĞdžƉƌĞƐƐŝŽŶŽĨɲͲƐLJŶƵĐůĞŝŶ ŝŶ ŶƵŵĞƌŽƵƐ ĂŶŝŵĂů ŵŽĚĞůƐ ŝŶĐůƵĚŝŶŐ ŝŶ ƚŚĞ ĨƌƵŝƚ ŇLJ͕39-41 Drosophila melanogaster, ƌĞĐĂƉŝƚƵůĂƚĞƐĨĞĂƚƵƌĞƐŽĨWͲƌĞůĂƚĞĚŶĞƵƌŽĚĞŐĞŶĞƌĂƟǀĞƉĂƚŚŽůŽŐLJ͘dƌĂŶƐŐĞŶŝĐĞdžƉƌĞƐƐŝŽŶ ŽĨɲͲƐLJŶƵĐůĞŝŶŝŶƚŚĞŇLJƌĞƟŶĂůĞĂĚƐƚŽŶĞƵƌŽƚŽdžŝĐĐŚĂŶŐĞƐ39ĂŶĚŝƐĂŵĞŶĂďůĞĨŽƌĚĞƚĞĐƟŽŶ ŽĨ ŐĞŶĞƟĐ ŵŽĚŝĮĞƌƐ͘42, 43 'ĞŶĞƟĐ ŵĂŶŝƉƵůĂƟŽŶ ŽĨ ĞƐƚĂďůŝƐŚĞĚ W ƐƵƐĐĞƉƟďŝůŝƚLJ ŐĞŶĞƐ͕

including PARK244, 45 and VPS35,46ŵŽĚƵůĂƚĞɲͲƐLJŶƵĐůĞŝŶƚŽdžŝĐŝƚLJŝŶƚƌĂŶƐŐĞŶŝĐŇŝĞƐ͕ƐŝŵŝůĂƌ

ƚŽĮŶĚŝŶŐƐŝŶŵĂŵŵĂůŝĂŶŵŽĚĞůƐ͘44, 47tĞƚŚĞƌĞĨŽƌĞŚLJƉŽƚŚĞƐŝnjĞĚƚŚĂƚ>Ž&ŝŶŚŽŵŽůŽŐƐŽĨ

ŶŽǀĞůWŐĞŶĞƐŵĂLJƐŝŵŝůĂƌůLJĞŶŚĂŶĐĞɲͲƐLJŶƵĐůĞŝŶͲŝŶĚƵĐĞĚƌĞƟŶĂůĚĞŐĞŶĞƌĂƟŽŶ͘

KƵƚŽĨƚŚĞϮϳĐĂŶĚŝĚĂƚĞŐĞŶĞƐŝŵƉůŝĐĂƚĞĚďLJŽƵƌt^ĂŶĂůLJƐĞƐ͕ϭϯǁĞƌĞǁĞůůͲ conserved in Drosophila ;^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϲͿ͘ǀĂŝůĂďůĞZEŝƐƚŽĐŬƐƚĂƌŐĞƟŶŐĞĂĐŚ ŽĨƚŚĞϭϴŇLJŚŽŵŽůŽŐƐ;ƐŽŵĞŐĞŶĞƐŚĂĚŵƵůƟƉůĞĐŽŶƐĞƌǀĞĚƉĂƌĂůŽŐƐͿǁĞƌĞĐƌŽƐƐĞĚƚŽ ŇŝĞƐ ŝŶ ǁŚŝĐŚ ƚŚĞ ŚƵŵĂŶ ɲͲƐLJŶƵĐůĞŝŶ ƚƌĂŶƐŐĞŶĞ ǁĂƐ ĚŝƌĞĐƚĞĚ ƚŽ ĂĚƵůƚ ƉŚŽƚŽƌĞĐĞƉƚŽƌƐ using the ZŚŽĚŽƉƐŝŶϭͲ'>ϰ;ZŚϭͿ driver (ZŚϭхɲͲƐLJŶƵĐůĞŝŶ).48&ŽƌƌĂƉŝĚƐĐƌĞĞŶŝŶŐ͕ƌĞƟŶĂů

(16)
(17)

6

ĞĂĐŚ ŽĨ ƚŚĞƐĞ ŐĞŶĞƐ ǁĞƌĞ ƚĂƌŐĞƚĞĚ ƵŶĚĞƌ ƐŝŵŝůĂƌ ĞdžƉĞƌŝŵĞŶƚĂů ĐŽŶĚŝƟŽŶƐ ;Rh1>RNAi), ďƵƚ ŝŶĚĞƉĞŶĚĞŶƚ ŽĨ ɲͲƐLJŶƵĐůĞŝŶ ĞdžƉƌĞƐƐŝŽŶ͕ ǁĞ ĚŝĚ ŶŽƚ ŽďƐĞƌǀĞ ĂŶLJ ƐŝŐŶŝĮĐĂŶƚ ƌĞƟŶĂů ƉĂƚŚŽůŽŐLJŝŶϭϱĚĂLJͲŽůĚĂŶŝŵĂůƐ;&ŝŐƵƌĞϱͿ͘dŚĞƌĞĨŽƌĞ͕ǁŝƚŚŝŶƚŚĞDrosophilaɲͲƐLJŶƵĐůĞŝŶ ƚƌĂŶƐŐĞŶŝĐŵŽĚĞůƐLJƐƚĞŵ͕ƚŚĞŝŵƉůŝĐĂƚĞĚ>Ž&ĞŶŚĂŶĐĞƌƐĂƉƉĞĂƌĐŽŶƐŝƐƚĞŶƚǁŝƚŚƐLJŶĞƌŐŝƐƟĐ ;ŶŽŶͲĂĚĚŝƟǀĞͿ ĞīĞĐƚƐ ŽŶ ɲͲƐLJŶƵĐůĞŝŶʹŵĞĚŝĂƚĞĚ ƌĞƟŶĂů ĚĞŐĞŶĞƌĂƟŽŶ͘ ^ŝŶĐĞ ŝŶĐƌĞĂƐĞĚ ɲͲƐLJŶƵĐůĞŝŶĞdžƉƌĞƐƐŝŽŶůĞǀĞůƐĂƌĞŽŶĞŝŵƉŽƌƚĂŶƚŵĞĐŚĂŶŝƐŵŽĨWƐƵƐĐĞƉƟďŝůŝƚLJ͕5 western ďůŽƚƐǁĞƌĞƉĞƌĨŽƌŵĞĚƚŽĚĞƚĞƌŵŝŶĞǁŚĞƚŚĞƌĂŶLJŽĨƚŚĞŝĚĞŶƟĮĞĚŐĞŶĞƟĐĞŶŚĂŶĐĞƌƐĂůƚĞƌ ɲͲƐLJŶƵĐůĞŝŶƉƌŽƚĞŝŶůĞǀĞůƐ͘,ŽǁĞǀĞƌ͕ĨŽůůŽǁŝŶŐZEŝͲŵĞĚŝĂƚĞĚŬŶŽĐŬĚŽǁŶ͕ŶŽŶĞůĞĚƚŽ ƐŝŐŶŝĮĐĂŶƚĐŚĂŶŐĞƐ;^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϯͿ͘dŚƵƐ͕ǁĞŚLJƉŽƚŚĞƐŝnjĞƉŽƚĞŶƟĂůŝŶƚĞƌĂĐƟŽŶƐ ǁŝƚŚ ŵŽƌĞ ĚŽǁŶƐƚƌĞĂŵ ŵĞĐŚĂŶŝƐŵƐ ŽĨ ɲͲƐLJŶƵĐůĞŝŶ ŶĞƵƌŽƚŽdžŝĐŝƚLJ͘ &Žƌ ϯ ŽƵƚ ŽĨ ƚŚĞ ϰ candidate enhancers (ARSB, VPS13C, PTPRHͿ͕ĂǀĂŝůĂďůĞƐŝZEƐƉĞƌŵŝƩĞĚĂĚĚŝƟŽŶĂůƚĞƐƟŶŐ ŽĨŐĞŶĞŚŽŵŽůŽŐƐĂƐĐĂŶĚŝĚĂƚĞŵŽĚŝĮĞƌƐŝŶĂŶĞƐƚĂďůŝƐŚĞĚC. elegans ŵŽĚĞůŽĨɲͲƐLJŶƵĐůĞŝŶ ƚŽdžŝĐŝƚLJ͘49,ŽǁĞǀĞƌ͕ŶŽƐŝŐŶŝĮĐĂŶƚĚŝīĞƌĞŶĐĞƐǁĞƌĞĚĞƚĞĐƚĞĚŝŶƚŚĞɲͲƐLJŶƵĐůĞŝŶͲŝŶĚƵĐĞĚ

locomotor phenotype observed in 1 week old worms following knockdown of these genes ;^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϰͿ͘tĞƐƉĞĐƵůĂƚĞƚŚĂƚƚŚĞƐĞĐŽŶƚƌĂĚŝĐƚŽƌLJƌĞƐƵůƚƐŵŝŐŚƚƐƚĞŵĨƌŽŵ ĚŝīĞƌĞŶĐĞƐŝŶĂƐƐĂLJƐĞŶƐŝƟǀŝƚLJĂŶĚͬŽƌƟƐƐƵĞͲƐƉĞĐŝĮĐƚŽdžŝĐŵĞĐŚĂŶŝƐŵƐĂƐƚŚĞŇLJĂŶĚǁŽƌŵ ŵŽĚĞůƐĂƌĞďĂƐĞĚŽŶɲͲƐLJŶƵĐůĞŝŶĞdžƉƌĞƐƐŝŽŶŝŶƚŚĞƌĞƟŶĂǀĞƌƐƵƐŵƵƐĐůĞ͕ƌĞƐƉĞĐƟǀĞůLJ͘

KĨƚŚĞϰŐĞŶĞƐĚŝƐĐŽǀĞƌĞĚƚŽŝŶƚĞƌĂĐƚǁŝƚŚɲͲƐLJŶƵĐůĞŝŶƚŽdžŝĐŝƚLJŝŶDrosophila, we ǁĞƌĞĂďůĞƚŽŽďƚĂŝŶĂĚĚŝƟŽŶĂůŐĞŶĞƟĐƌĞĂŐĞŶƚƐ͕ŝŶĐůƵĚŝŶŐĐůĂƐƐŝĐĂů>Ž&ĂůůĞůĞƐ͕ĨŽƌƚŚĞϮ homologs of PTPRH, Ptp10D and WƚƉϰ͘/ŶŽƵƌƐĐƌĞĞŶ͕ϮŝŶĚĞƉĞŶĚĞŶƚZEŝůŝŶĞƐƚĂƌŐĞƟŶŐ

Ptp10D ƌŽďƵƐƚůLJ ĞŶŚĂŶĐĞĚ ɲͲƐLJŶƵĐůĞŝŶ ƚŽdžŝĐŝƚLJ͕ ďƵƚ ŽŶůLJ ϭ ŽĨ ƚŚĞ Ϯ ĂǀĂŝůĂďůĞ ůŝŶĞƐ ĨŽƌ WƚƉϰŵĞƚŽƵƌƚŚƌĞƐŚŽůĚĐƌŝƚĞƌŝĂ;^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϳͿ͘/ŶƚĞƌĞƐƟŶŐůLJƉƌŝŽƌƐƚƵĚŝĞƐŝŶ Drosophila suggest that Ptp10D and WƚƉϰ ĂƌĞ ƚŚĞ ƌĞƐƵůƚ ŽĨ Ă ŐĞŶĞ ĚƵƉůŝĐĂƟŽŶ ĞǀĞŶƚ͕

ĂŶĚƚŚĞƐĞŐĞŶĞƐƐŚŽǁĞǀŝĚĞŶĐĞŽĨƉĂƌƟĂůĨƵŶĐƟŽŶĂůƌĞĚƵŶĚĂŶĐLJ͕ŝŶĐůƵĚŝŶŐĨŽƌŶĞƌǀŽƵƐ system phenotypes.50ŽŶƐŝƐƚĞŶƚǁŝƚŚƚŚŝƐ͕ǁĞĨŽƵŶĚƚŚĂƚƚƌĂŶƐŚĞƚĞƌŽnjLJŐŽƐŝƚLJĨŽƌƐƚƌŽŶŐ ;ŶƵůůͿĂůůĞůĞƐŽĨďŽƚŚŐĞŶĞƐĞŶŚĂŶĐĞĚɲͲƐLJŶƵĐůĞŝŶͲŝŶĚƵĐĞĚƌĞƟŶĂůĚĞŐĞŶĞƌĂƟŽŶ;WƚƉϰ1, Ptp10D1ͬн͖ZŚϭͲ'Ăůϰͬн͖h^ͲɲͲƐLJŶƵĐůĞŝŶͬнͿ͖ǁŚĞƌĞĂƐŚĞƚĞƌŽnjLJŐŽƐŝƚLJĨŽƌĞŝƚŚĞƌĂůůĞůĞŝŶ ŝƐŽůĂƟŽŶƐŚŽǁĞĚŶŽƐŝŐŶŝĮĐĂŶƚĞŶŚĂŶĐĞŵĞŶƚ;&ŝŐƵƌĞϱĂŶĚ^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϱͿ͘ 'ĞŶĞƟĐƌĞƉůŝĐĂƟŽŶŽĨĐĂŶĚŝĚĂƚĞWŐĞŶĞƐĨƌŽŵt^ tĞŶĞdžƚĞǀĂůƵĂƚĞĚŽƵƌϮϳŐĞŶĞĐĂŶĚŝĚĂƚĞƐŝŶĂĚĚŝƟŽŶĂůĂǀĂŝůĂďůĞŐĞŶĞƟĐĚĂƚĂƐĞƚƐŝŶĐůƵĚŝŶŐ ;ϭͿĂŶŝŶĚĞƉĞŶĚĞŶƚĞdžŽŵĞƐĞƋƵĞŶĐŝŶŐĚĂƚĂƐĞƚĨƌŽŵƚŚĞWĂƌŬŝŶƐŽŶWƌŽŐƌĞƐƐŝŽŶDĂƌŬĞƌƐ /ŶŝƟĂƟǀĞ ;WWD/Ϳ ƉƌŽũĞĐƚ͕51 ;ϮͿ Ă ǁŚŽůĞ ŐĞŶŽŵĞ ƐĞƋƵĞŶĐŝŶŐ ĚĂƚĂƐĞƚ ŝŶĐůƵĚŝŶŐ W ŝŶĚĞdž ĐĂƐĞƐŽĨĂƵƚĐŚŐĞŶĞƟĐŝƐŽůĂƚĞďĞůŽŶŐŝŶŐƚŽƚŚĞ'ĞŶĞƟĐZĞƐĞĂƌĐŚŝŶ/ƐŽůĂƚĞĚWŽƉƵůĂƟŽŶ ;'Z/WͿƉƌŽŐƌĂŵ͕52;ϯͿĂŶŝŶĚĞƉĞŶĚĞŶƚEĞƵƌŽyĞdžŽŵĞĂƌƌĂLJĚĂƚĂƐĞƚ͕7, 53 and (4) a large PD

't^ĚĂƚĂƐĞƚ͘53tŝƚŚŝŶƚŚĞWWD/ĞdžŽŵĞĚĂƚĂƐĞƚ͕ŝŶĐůƵĚŝŶŐϰϲϮWĐĂƐĞƐĂŶĚϭϴϯĐŽŶƚƌŽůƐ͕

(18)
(19)

6

ĂƐŽďƐĞƌǀĞĚĨŽƌĂŶ/W'ĐĂƐĞ͘ůƚŚŽƵŐŚƚŚĞĂŐĞŽĨŽŶƐĞƚĚŝīĞƌƐϮϬLJĞĂƌƐďĞƚǁĞĞŶƚŚĞƐĞ ƚǁŽWĐĂƐĞƐ;ϰϳĂŶĚϲϴLJĞĂƌƐĨŽƌƚŚĞ/W'ĂŶĚWWD/ƉĂƟĞŶƚ͕ƌĞƐƉĞĐƟǀĞůLJͿ͕ƚŚĞLJƐŚĂƌĞ ƐŝŵŝůĂƌĂƐLJŵŵĞƚƌŝĐĐůŝŶŝĐĂůƐLJŵƉƚŽŵƐĂƚŽŶƐĞƚ͕ǁŚŝĐŚĂƌĞĐŚĂƌĂĐƚĞƌŝnjĞĚďLJƌĞƐƟŶŐƚƌĞŵŽƌ͕ ďƌĂĚLJŬŝŶĞƐŝĂĂŶĚƌŝŐŝĚŝƚLJ͘&ƵƌƚŚĞƌŵŽƌĞ͕ďŽƚŚWĐĂƐĞƐŚĂǀĞĂĨĂƚŚĞƌĚŝĂŐŶŽƐĞĚǁŝƚŚW͕ ŝŵƉůLJŝŶŐƚŚĞǀĂƌŝĂŶƚƚŽďĞŚŝŐŚůLJƉĞŶĞƚƌĂŶƚ͘tĞĞdžĐůƵĚĞĚƚŚĞƉŽƐƐŝďŝůŝƚLJƚŚĂƚƚŚĞƐĞƚǁŽ WĐĂƐĞƐŵŝŐŚƚďĞƌĞůĂƚĞĚďLJĐŽŵƉƵƟŶŐƉĂŝƌǁŝƐĞŐĞŶĞƟĐƌĞůĂƟŽŶƐŚŝƉƐ54 from common ^EWƐ;D&шϬ͘ϬϭͿ͘EŽĞǀŝĚĞŶĐĞŽĨƌĞůĂƚĞĚŶĞƐƐǁĂƐŽďƐĞƌǀĞĚ;jk = -0.0018). Based on dž͕ŽŶůLJŽŶĞ;Ϭ͘ϬϬϯйͿŽƵƚŽĨϯϮ͕ϲϰϳƵƌŽƉĞĂŶŝŶĚŝǀŝĚƵĂůƐŚĂƐƚŚŝƐƐĂŵĞŚŽŵŽnjLJŐŽƵƐ ǀĂƌŝĂŶƚ͘dŚĞŽďƐĞƌǀĂƟŽŶŽĨƚǁŽWĐĂƐĞƐ;Ϭ͘ϭϮйͿŽĨŽƵƌϭ͕ϲϭϬƐƚƵĚŝĞĚWƉĂƟĞŶƚƐ;ϭ͕ϭϰϴ /W't^ƉůƵƐϰϲϮWWD/t^ͿǁŝƚŚƚŚŝƐGPATCH2L ŵƵƚĂƟŽŶŝƐĐŽŶƐŝƐƚĞŶƚǁŝƚŚĂϰϬͲ ĨŽůĚĞŶƌŝĐŚŵĞŶƚŝŶŽƵƌWĐŽŚŽƌƚ͘dŚĞƐĞĐŽŶĚŐĞŶĞŚĂƌďŽƌŝŶŐĂŶŝĚĞŶƟĐĂů>Ž&ǀĂƌŝĂŶƚŝƐ &Dϴϯ͘dŚĞƉ͘'ϴϲyǀĂƌŝĂŶƚŝŶ&Dϴϯ͕ĚĞƚĞĐƚĞĚǁŝƚŚŝŶĂŶ/W'ƐƵďũĞĐƚǁŝƚŚƐƉŽƌĂĚŝĐ

(20)

6

dŚŝƐŐĞŶĞĂůƐŽƐŚŽǁƐĂŶĂƐƐŽĐŝĂƟŽŶǁŝƚŚWŝŶƚŚĞ/W't^ĚĂƚĂƐĞƚǁŚĞŶƉĞƌĨŽƌŵŝŶŐ a similar burden analysis considering missense variants (see above, p с Ϭ͘ϬϭϲͿ͘ hƐŝŶŐ ƚŚĞEĞƵƌŽyĚĂƚĂƐĞƚ͕ǁĞĂĚĚŝƟŽŶĂůůLJĐŽŶĮƌŵĞĚƚŚĞĞŶƌŝĐŚŵĞŶƚŽĨƌĂƌĞPTPRH variants in subjects with PD (WES: p=0.034, NeuroX: pсϬ͘ϬϰϱͿ͘&ƵƌƚŚĞƌŵŽƌĞ͕VPS13C and ARSB ƐŚŽǁƐŝŐŶŝĮĐĂŶƚĂƐƐŽĐŝĂƟŽŶƐƚŽWǁŚĞŶĐŽŶƐŝĚĞƌŝŶŐƚŚĞũŽŝŶƚĞīĞĐƚŽĨĂůůǀĂƌŝĂŶƚƐ͕ďŽƚŚ common and rare (Supplementary Table 9).

>ĞǀĞƌĂŐŝŶŐĂǀĂŝůĂďůĞ/W''t^ĚĂƚĂ;ϭϯ͕ϳϬϴĐĂƐĞƐͬϵϱ͕ϮϴϮĐŽŶƚƌŽůƐͿǁĞŶĞdžƚ ĂƐƐĞƐƐĞĚĨŽƌƉŽƚĞŶƟĂůĐŽŵŵŽŶǀĂƌŝĂŶƚĂƐƐŽĐŝĂƟŽŶƐŝŐŶĂůƐ;p фϭdžϭϬ-4), using a 1Mb genomic

window centered on each of the 27 candidate genes. Three loci (VPS13C, PCDHA9, and

TCHHL1ͿƐŚŽǁĞĚĞǀŝĚĞŶĐĞĐŽŶƐŝƐƚĞŶƚǁŝƚŚĂŶĂƐƐŽĐŝĂƟŽŶƉĞĂŬ;^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϲͿ͘

ŐĞŶŽŵĞǁŝĚĞƐŝŐŶŝĮĐĂŶƚĂƐƐŽĐŝĂƟŽŶĂƚƚŚĞVPS13C locus, was in fact recently reported7͖

the best SNP (rs2414739, p сϯ͘ϱϵdžϭϬ-12ͿŵĂƉƐΕϭϱϬŬďĚŝƐƚĂůƚŽVPS13C. Based on local

ƉĂƩĞƌŶƐ ŽĨ ůŝŶŬĂŐĞ ĚŝƐĞƋƵŝůŝďƌŝƵŵ ĚĞĮŶĞĚ ďLJ ,ĂƉŵĂƉ ;^ƵƉƉůĞŵĞŶƚĂƌLJ &ŝŐƵƌĞ ϲͿ͕ ŝƚ ŝƐ ƵŶůŝŬĞůLJƚŚĂƚƌƐϮϰϭϰϳϯϵŝƐĂƉƌŽdžLJĨŽƌƉ͘ϯϭϰϳyŽƌƐŝŵŝůĂƌ>Ž&ǀĂƌŝĂŶƚƐŝŶsW^ϭϯ͖however, ŝƚŵŝŐŚƚďĞƉŽƐƐŝďůĞƚŚĂƚƚŚĞ^EWŝŶŇƵĞŶĐĞƐ VPS13CĞdžƉƌĞƐƐŝŽŶďLJĂīĞĐƟŶŐƚŚĞůŽŶŐŶŽŶͲ ĐŽĚŝŶŐZEůŶĐͲsW^ϭϯͲϭ55ŝŶǁŚŝĐŚƚŚĞ^EWŝƐůŽĐĂƚĞĚ͘dŚĞŽƚŚĞƌϮĐĂŶĚŝĚĂƚĞĂƐƐŽĐŝĂƟŽŶ

peaks, adjacent to PCDHA9 and TCHHL1, are considerably weaker signals (rs349129 = 1.40 džϭϬ-5ĂŶĚƌƐϳϱϮϵϱϯϱсϳ͘ϲϲdžϭϬ-5͕ƌĞƐƉĞĐƟǀĞůLJͿĂŶĚŐŝǀĞŶƚŚĞĚŝƐƚĂŶĐĞƐ;ΕϱϬϬŬďͿŵĂŶLJ

ŽƚŚĞƌĐĂŶĚŝĚĂƚĞŐĞŶĞƐĂƌĞƉŽƚĞŶƟĂůůLJŝŵƉůŝĐĂƚĞĚ͘

/ŶƐƵŵ͕ǁĞŝĚĞŶƟĨLJĂĚĚŝƟŽŶĂů ŐĞŶĞƟĐĞǀŝĚĞŶĐĞĐŽŶƐŝƐƚĞŶƚǁŝƚŚƌĞƉůŝĐĂƟŽŶĨŽƌ 7 genes ('Wd,Ϯ>͕&Dϴϯ͕ϯϲ͕h,Z&ϭWϭ>͕WdWZ,͕Z^and VPS13C) that were implicated by our WES analysis, of which 5 ('Wd,Ϯ>͕h,Z&ϭWϭ>͕WdWZ,͕ ARSB and

(21)

6

ĚĞŶŽƚĞƉŽƚĞŶƟĂůĨƵŶĐƟŽŶƐ͘h,Z&ϭWϭ>ǁĂƐĐŽͲĞdžƉƌĞƐƐĞĚǁŝƚŚSNCA, PINK1, GBA, and

ATP13A2ŝŶĂŶĞƚǁŽƌŬƐŝŐŶŝĮĐĂŶƚůLJĞŶƌŝĐŚĞĚĨŽƌŐĞŶĞƐǁŝƚŚƌŽůĞƐŝŶƐLJŶĂƉƟĐƚƌĂŶƐŵŝƐƐŝŽŶ

(pсϮ͘ϮϳdžϭϬ-11Ϳ ĂƐ ǁĞůů ĂƐ ĂƐƚƌŽĐLJƟĐ ;pсϴ͘ϭϴdžϭϬ-8) and dopaminergic neuronal markers

(pсϯ͘ϵϴdžϭϬ-46). GPATCH2LǁĂƐĐŽͲĞdžƉƌĞƐƐĞĚǁŝƚŚPARK7 in a network enriched for other

neuronal genes (pсϯ͘ϰϭdžϭϬ-12) with cellular roles in metabolism of macromolecules

(pсϯ͘ϴϮdžϭϬ-15). Lastly, PTPRHǁĂƐĂƐƐŝŐŶĞĚƚŽĂĐŽͲĞdžƉƌĞƐƐŝŽŶŵŽĚƵůĞŝŶĐůƵĚŝŶŐ&yϬϳ and

enriched for oligodendrocyte markers (pсϴ͘ϲϵdžϭϬ-22). Importantly, the implicated modules

ǁĞƌĞƉƌĞƐĞƌǀĞĚ;͘ƐƵŵŵĂƌLJхсϭϬͿŝŶƚŚĞŝŶĚĞƉĞŶĚĞŶƚ'ddžĚĂƚĂƐĞƚ͘

/^h^^/KE

We report the results from WES analysis in the largest PD cohort studied to date. Assuming a ƌĞĐĞƐƐŝǀĞŝŶŚĞƌŝƚĂŶĐĞŵŽĚĞů͕ǁĞŝĚĞŶƟĮĞĚϮϳĐĂŶĚŝĚĂƚĞŐĞŶĞƐŚĂƌďŽƌŝŶŐƌĂƌĞŚŽŵŽnjLJŐŽƵƐ ŽƌĐŽŵƉŽƵŶĚŚĞƚĞƌŽnjLJŐŽƵƐ>Ž&ǀĂƌŝĂŶƚƐ͘tŝƚŚƚŚĞĞdžĐĞƉƟŽŶŽĨARSB͕ǁĞĚŝĚŶŽƚŝĚĞŶƟĨLJ ƌĞĐƵƌƌĞŶƚƌĞĐĞƐƐŝǀĞĂůůĞůĞƐŝŶŵŽƌĞƚŚĂŶĂƐŝŶŐůĞWĐĂƐĞ͘dŚŝƐƌĞƐƵůƚͶƉŽƚĞŶƟĂůůLJĐŽŶƐŝƐƚĞŶƚ ǁŝƚŚ Ă ŚŝŐŚůLJ ŚĞƚĞƌŽŐĞŶĞŽƵƐ ŐĞŶĞƟĐ ĞƟŽůŽŐLJ ĨŽƌ WͶĐƌĞĂƚĞƐ ƐŝŐŶŝĮĐĂŶƚ ďĂƌƌŝĞƌƐ ĨŽƌ ƐƚĂƟƐƟĐĂůĐŽŶĮƌŵĂƟŽŶĂŶĚŐĞŶĞƟĐƌĞƉůŝĐĂƟŽŶŽĨŶŽǀĞůWƐƵƐĐĞƉƟďŝůŝƚLJůŽĐŝ͘ĚĚŝƟŽŶĂů ŐĞŶĞƟĐ ƐĂŵƉůĞƐ ǁĞƌĞ ŶŽƚ ĂǀĂŝůĂďůĞ ĨŽƌ ƐĞŐƌĞŐĂƟŽŶ ĂŶĂůLJƐŝƐ͕ ĂŶĚ ŐŝǀĞŶ ƚŚĞ ƌĂƌŝƚLJ ĂŶĚ ŚĞƚĞƌŽŐĞŶĞŝƚLJŽĨƚŚĞŝŵƉůŝĐĂƚĞĚĂůůĞůĞƐ͕ĚĞĮŶŝƟǀĞŚƵŵĂŶŐĞŶĞƟĐƌĞƉůŝĐĂƟŽŶǁŽƵůĚůŝŬĞůLJ ƌĞƋƵŝƌĞǀĞƌLJůĂƌŐĞƐĂŵƉůĞƐŝnjĞƐ͕ŝŶĐůƵĚŝŶŐŵĂŶLJƚŚŽƵƐĂŶĚƐŽĨWĐĂƐĞƐǁŝƚŚĞŝƚŚĞƌt^ ŽƌŐĞŶĞƌĞƐĞƋƵĞŶĐŝŶŐ͘tĞƚŚĞƌĞĨŽƌĞĐŽƵƉůĞĚŽƵƌt^ĂŶĂůLJƐĞƐǁŝƚŚĨƵŶĐƟŽŶĂůƐƚƵĚŝĞƐ ŝŶďŽƚŚŵĂŵŵĂůŝĂŶĐĞůůƐĂŶĚĞdžƉĞƌŝŵĞŶƚĂůĂŶŝŵĂůŵŽĚĞůƐ͕ŝŶĐůƵĚŝŶŐDrosophila and C. elegans͕ŝŶŽƌĚĞƌƚŽƉƌŝŽƌŝƟnjĞŐĞŶĞƐĨŽƌĨƵƚƵƌĞƐƚƵĚLJ͘KƵƌƌĞƐƵůƚƐŚŝŐŚůŝŐŚƚϭϱŽƵƚŽĨƚŚĞ

(22)

6

ůŽĐŝĐĂŶĚŝĚĂƚĞƐĨŽƌĨƵƌƚŚĞƌŝŶǀĞƐƟŐĂƟŽŶ͕ĂŶĚŝůůƵƐƚƌĂƚĞĂƉŽǁĞƌĨƵů͕ŝŶƚĞŐƌĂƟǀĞĚŝƐĐŽǀĞƌLJ strategy for future, large-scale PD genomic studies.

Mitochondrial mechanisms have been strongly implicated in PD risk and pathogenesis.28, 30 &ŽůůŽǁŝŶŐ ƐŚZEͲŵĞĚŝĂƚĞĚ ŬŶŽĐŬĚŽǁŶ͕ ϭϱ ĐĂŶĚŝĚĂƚĞ ƌĞĐĞƐƐŝǀĞ

ůŽĐŝ ŝĚĞŶƟĮĞĚ ŝŶ ŽƵƌ t^ ĚĂƚĂƐĞƚ ƐŚŽǁĞĚ ĞīĞĐƚƐ ŽŶ ŵŝƚŽĐŚŽŶĚƌŝĂů ŵŽƌƉŚŽůŽŐLJ ĂŶĚ WĂƌŬŝŶƚƌĂŶƐůŽĐĂƟŽŶƚŽŵŝƚŽĐŚŽŶĚƌŝĂŝŶĐĞůůĐƵůƚƵƌĞ͘tĞĨŽĐƵƐŽƵƌŝŶŝƟĂůĚŝƐĐƵƐƐŝŽŶŽŶϯ genes, 'Wd,Ϯ>͕h,Z&ϭWϭ>͕and VPS13C͕ĨŽƌǁŚŝĐŚǁĞĚŝƐĐŽǀĞƌĞĚĂĚĚŝƟŽŶĂůŐĞŶĞƟĐ ĞǀŝĚĞŶĐĞ ĐŽŶƐŝƐƚĞŶƚ ǁŝƚŚ ƌĞƉůŝĐĂƟŽŶ ŝŶ ŝŶĚĞƉĞŶĚĞŶƚ ĐŽŚŽƌƚƐ͘ /Ŷ ƚŚĞ /W' ĐŽŚŽƌƚ͕ Ă ƐŝŶŐůĞWĐĂƐĞǁĂƐŝĚĞŶƟĮĞĚǁŝƚŚĂŚŽŵŽnjLJŐŽƵƐƐƚŽƉŐĂŝŶǀĂƌŝĂŶƚ;Ɖ͘ZϯϲϮyͿŝŶGPATCH2L, ĂŶĚĂƐĞĐŽŶĚŝŶĚŝǀŝĚƵĂůǁŝƚŚƚŚĞŝĚĞŶƟĐĂů͕ƌĂƌĞŐĞŶŽƚLJƉĞǁĂƐĚŝƐĐŽǀĞƌĞĚŝŶWWD/͘dŚŝƐ ǀĂƌŝĂŶƚŝƐƌĞƉŽƌƚĞĚǁŝƚŚĂůŽǁĨƌĞƋƵĞŶĐLJŽĨϬ͘ϬϬϯйŝŶdž͘ůƚŚŽƵŐŚŵŝŶŝŵĂůĐůŝŶŝĐĂů Žƌ ĚĞŵŽŐƌĂƉŚŝĐ ŝŶĨŽƌŵĂƟŽŶ ŝƐ ĂǀĂŝůĂďůĞ ǁŝƚŚŝŶ dž͕ ƚŚŝƐ ĮŶĚŝŶŐ ŝƐ ĐŽŵƉĂƟďůĞ ǁŝƚŚ ƉŽƉƵůĂƟŽŶ ƉƌĞǀĂůĞŶĐĞ ĞƐƟŵĂƚĞƐ ĨŽƌ W͘20 EĞǀĞƌƚĞŚĞůĞƐƐ͕ ŐĞŶŽƚLJƉŝŶŐ ŽĨ Ɖ͘ZϯϲϮy ŝŶ ĂĚĚŝƟŽŶĂůůĂƌŐĞWĐĂƐĞĂŶĚĐŽŶƚƌŽůĐŽŚŽƌƚƐǁŝůůďĞƌĞƋƵŝƌĞĚƚŽĚĞĮŶŝƟǀĞůLJĞƐƚĂďůŝƐŚĂŶ ĂƐƐŽĐŝĂƟŽŶǁŝƚŚWƐƵƐĐĞƉƟďŝůŝƚLJ͘ GPATCH2L knockdown both increased mitochondrial ƌŽƵŶĚŶĞƐƐ ĂŶĚ ŝŵƉĂŝƌĞĚ WĂƌŬŝŶ ƚƌĂŶƐůŽĐĂƟŽŶ͘ dŚĞ ĞŶĐŽĚĞĚ ƉƌŽƚĞŝŶ͕ 'Wd,Ϯ>͕ ǁŚŝĐŚ ŚĂƐŶŽƚƉƌĞǀŝŽƵƐůLJďĞĞŶƐƚƵĚŝĞĚ͕ĐŽŶƚĂŝŶƐĂŐůLJĐŝŶĞͲƌŝĐŚZEͲďŝŶĚŝŶŐŵŽƟĨ͕ƚŚĞ͞'ͲƉĂƚĐŚ͟ domain.57 GPATCH2, a paralog of GPATCH2L͕ŝƐƵƉƌĞŐƵůĂƚĞĚŝŶĐĂŶĐĞƌĐĞůůƐ͕ůŽĐĂůŝnjĞƐƚŽƚŚĞ

ŶƵĐůĞƵƐǁŚĞƌĞŝƚŝŶƚĞƌĂĐƚƐǁŝƚŚZEͲƉƌŽĐĞƐƐŝŶŐŵĂĐŚŝŶĞƌLJ͕ĂŶĚŵĂŶŝƉƵůĂƟŽŶŝŶĐƵůƚƵƌĞ ĂůƚĞƌƐĐĞůůƉƌŽůŝĨĞƌĂƟŽŶ͘58, 59 Notably, GPATCH2L is non-conserved in either the C. elegans or Drosophila genomes, precluding study of this candidate in these models. While our results

using cellular assays implicate GPATCH2L in mitochondrial quality control mechanisms, ĨƵƌƚŚĞƌĨŽůůŽǁͲƵƉƐƚƵĚŝĞƐŝŶŵĂŵŵĂůŝĂŶŵŽĚĞůƐLJƐƚĞŵƐǁŝůůďĞŶĞĞĚĞĚƚŽĐŽŶĮƌŵĂƌŽůĞŝŶ PD pathogenesis.

Another promising gene, h,Z&ϭWϭ>, ŚĂƌďŽƌĞĚĂŚŽŵŽnjLJŐŽƵƐƐƚŽƉŐĂŝŶǀĂƌŝĂŶƚ ;Đ͘ϰϭϮϲхd͕Ɖ͘<ϭϯϳϲyͿŝŶĂƐŝŶŐůĞ/W'ĐĂƐĞ͘dŚŝƐŝƐĂŶŽǀĞůǀĂƌŝĂŶƚ͕ďĂƐĞĚŽŶŝƚƐĂďƐĞŶĐĞ ĨƌŽŵƚŚĞdžĐŽŚŽƌƚ͘ĚĚŝƟŽŶĂůƐƵƉƉŽƌƚĨŽƌh,Z&ϭWϭ>as a ďŽŶĂĮĚĞ PD locus, comes ĨƌŽŵĐŽŵƉůĞŵĞŶƚĂƌLJĂŶĂůLJƐĞƐŝŶďŽƚŚƚŚĞ/W't^ĂŶĚEĞƵƌŽyĚĂƚĂƐĞƚƐ͕ĚŽĐƵŵĞŶƟŶŐ ĂďƵƌĚĞŶŽĨƌĂƌĞŵŝƐƐĞŶƐĞĂŶĚ>Ž&ǀĂƌŝĂŶƚƐŝŶĂƐƐŽĐŝĂƟŽŶǁŝƚŚĚŝƐĞĂƐĞƌŝƐŬ͘/ŶƚŚĞh<͕

h,Z&ϭWϭ>ǁĂƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚĂƐƵďƐƚĂŶƟĂŶŝŐƌĂĐŽͲĞdžƉƌĞƐƐŝŽŶŵŽĚƵůĞŝŶĐůƵĚŝŶŐďŽƚŚ SNCA and PINK1͕ ƌĞŝŶĨŽƌĐŝŶŐ ƉŽƚĞŶƟĂů ůŝŶŬƐ ǁŝƚŚ ĞƐƚĂďůŝƐŚĞĚ W ŐĞŶĞƟĐ ŵĞĐŚĂŶŝƐŵƐ͘

Indeed, h,Z&ϭWϭ> knockdown cause sharply reduced mitochondrial numbers and ĂůƚĞƌĞĚ ŵŽƌƉŚŽůŽŐLJ͘ /ŶƚĞƌĞƐƟŶŐůLJ͕ h,Z&ϭWϭ> encodes a protein bearing an amino terminal homologous to yeast VPS13, and studies in cell culture provide support for a role ŝŶƌĞƚƌŽŐƌĂĚĞƚƌĂŶƐƉŽƌƚĨƌŽŵƚŚĞĞŶĚŽƐŽŵĞƚŽƚŚĞƚƌĂŶƐͲ'ŽůŐŝŶĞƚǁŽƌŬ͘60

(23)

6

WƐƵƐĐĞƉƟďŝůŝƚLJǀĂƌŝĂŶƚƐďĂƐĞĚŽŶ't^͘7KƵƌĮŶĚŝŶŐƐŽĨĂƉŽƚĞŶƟĂůŵŝƚŽĐŚŽŶĚƌŝĂůƌŽůĞ

for VPS13C͕ ĂŐƌĞĞ ǁŝƚŚ ƚŚŽƐĞ ŽĨ >ĞƐĂŐĞ Ğƚ Ăů͕͘ ǁŚŽ ĂĚĚŝƟŽŶĂůůLJ ƌĞƉŽƌƚĞĚ ƚŚĂƚ sW^ϭϯ ůŽĐĂůŝnjĞƐƚŽƚŚĞŽƵƚĞƌŵĞŵďƌĂŶĞŽĨŵŝƚŽĐŚŽŶĚƌŝĂĂŶĚ>Ž&ǁĂƐĂƐƐŽĐŝĂƚĞĚǁŝƚŚƌĞĚƵĐĞĚ ŵŝƚŽĐŚŽŶĚƌŝĂů ŵĞŵďƌĂŶĞ ƉŽƚĞŶƟĂů͕ ĨƌĂŐŵĞŶƚĂƟŽŶ͕ ĂŶĚ ŝŶĐƌĞĂƐĞĚ WĂƌŬŝŶͲĚĞƉĞŶĚĞŶƚ mitophagy. Importantly, VPS35, which causes autosomal dominant, late-onset PD, is ƐŝŵŝůĂƌůLJ ŝŶǀŽůǀĞĚ ŝŶ ĞŶĚŽƐŽŵĂů ƚƌĂĸĐŬŝŶŐ͕61 and has also recently been implicated

in mitochondrial dynamics,62 ŝŶĐůƵĚŝŶŐ ŝŶƚĞƌĂĐƟŽŶƐ ǁŝƚŚ WĂƌŬŝŶ͘63 Like h,Z&ϭWϭ>͕ VPS13C and GPATCH2L ĂƌĞĞdžƉƌĞƐƐĞĚŝŶƚŚĞďƌĂŝŶ͕ŝŶĐůƵĚŝŶŐǁŝƚŚŝŶƚŚĞƐƵďƐƚĂŶƟĂŶŝŐƌĂ͖

ŚŽǁĞǀĞƌ͕ ĂĚĚŝƟŽŶĂů ǁŽƌŬ ǁŝůů ďĞ ŶĞĞĚĞĚ ƚŽ ĚĞĮŶĞ ƚŚĞŝƌ ĨƵŶĐƟŽŶƐ͕ ŝŶĐůƵĚŝŶŐ ƉŽƚĞŶƟĂů ŝŶƚĞƌĂĐƟŽŶƐǁŝƚŚŽƚŚĞƌĞƐƚĂďůŝƐŚĞĚĚŝƐĞĂƐĞŐĞŶĞƐ;e.g. VPS35, parkin) and requirements for mitochondrial maintenance.

ĂƐĞĚŽŶĨƵŶĐƟŽŶĂůƐĐƌĞĞŶŝŶŐŝŶDrosophila, 4 candidate genes from our WES ĂŶĂůLJƐĞƐǁĞƌĞŝŵƉůŝĐĂƚĞĚĂƐ>Ž&ĞŶŚĂŶĐĞƌƐŽĨɲͲƐLJŶƵĐůĞŝŶŶĞƵƌŽƚŽdžŝĐŝƚLJ͕ǁŚŝĐŚĂůƐŽŚĂƐ a central role in PD pathogenesis. We discuss the 3 genes (VPS13C, PTPRH, and ARSB) ǁŚĞƌĞĂĚĚŝƟŽŶĂůŚƵŵĂŶŐĞŶĞƟĐĞǀŝĚĞŶĐĞƐƵƉƉŽƌƚƐƌĞƉůŝĐĂƟŽŶ͘/ŶƚĞƌĞƐƟŶŐůLJ͕ďĞƐŝĚĞƐŝƚƐ ƌĞƋƵŝƌĞŵĞŶƚ ĨŽƌ ŵŝƚŽĐŚŽŶĚƌŝĂů ŵĂŝŶƚĞŶĂŶĐĞ͕ ZEŝͲŵĞĚŝĂƚĞĚ ŬŶŽĐŬĚŽǁŶ ŽĨ Drosophila

Vps13 ĞŶŚĂŶĐĞĚ ɲͲƐLJŶƵĐůĞŝŶ ƚŽdžŝĐŝƚLJ͘ /Ŷ ƚŚĞ ƐŝŶŐůĞ ƌĞƉŽƌƚĞĚ VPS13C PD case with a

ĐŽŵƉůĞƚĞĚĂƵƚŽƉƐLJ͕ŶĞƵƌŽƉĂƚŚŽůŽŐŝĐĂůĮŶĚŝŶŐƐŝŶĐůƵĚĞĚĂďƵŶĚĂŶƚɲͲƐLJŶƵĐůĞŝŶĂŐŐƌĞŐĂƚĞƐ ŝŶ ďŽƚŚ ƚŚĞ ďƌĂŝŶƐƚĞŵ ĂŶĚ ĐŽƌƚĞdž͘21 Thus, VPS13C ĂŶĚ ĂƐƐŽĐŝĂƚĞĚ ĞŶĚŽƐŽŵĂů ƐŽƌƟŶŐ

pathways (including VPS35) may represent a point of convergence for mitochondrial and ɲͲƐLJŶƵĐůĞŝŶͲŵĞĚŝĂƚĞĚWŵĞĐŚĂŶŝƐŵƐ͘ŽŶƐŝƐƚĞŶƚǁŝƚŚƚŚŝƐ͕ĞǀŝĚĞŶĐĞĨŽƌƚŚĞŝŵƉĂĐƚŽĨ ɲͲƐLJŶƵĐůĞŝŶ ƚŽdžŝĐŝƚLJŽŶŵŝƚŽĐŚŽŶĚƌŝĂŚĂƐƌĞĐĞŶƚůLJĞŵĞƌŐĞĚ͕28 including from studies in

mammals.64 /Ŷ ƚŚĞ /W' t^ ĐŽŚŽƌƚ͕ Ă ƐŝŶŐůĞ W ĐĂƐĞ ǁĂƐ ĚŝƐĐŽǀĞƌĞĚ ǁŝƚŚ ĐŽŵƉŽƵŶĚ ŚĞƚĞƌŽnjLJŐŽƵƐ>Ž&ǀĂƌŝĂŶƚƐŝŶPTPRH;Đ͘Ϯϲϱϵхd͕Ɖ͘YϴϴϳyĂŶĚĐ͘ϱϵϴ'хd͕Ɖ͘ϮϬϬyͿ͘ŽƚŚ ǀĂƌŝĂŶƚƐǁĞƌĞĂůƐŽŽďƐĞƌǀĞĚĂƚůŽǁĨƌĞƋƵĞŶĐŝĞƐŝŶƚŚĞdžĚĂƚĂďĂƐĞ;Ϭ͘ϬϯϵйĂŶĚϬ͘ϬϬϯй͕ ƌĞƐƉĞĐƟǀĞůLJͿ͖ŚŽǁĞǀĞƌ͕ƚŚĞLJĞĂĐŚŵĞƚŽƵƌƉƌĞͲƐƉĞĐŝĮĞĚƚŚƌĞƐŚŽůĚŽĨфϭйďĂƐĞĚŽŶƚŚĞ ƉŽƉƵůĂƟŽŶƉƌĞǀĂůĞŶĐĞŽĨW͘ŶĐŽĚŝŶŐĂƌĞĐĞƉƚŽƌƉƌŽƚĞŝŶƚLJƌŽƐŝŶĞƉŚŽƐƉŚĂƚĂƐĞ͕PTPRH (also called SAP-1ͿǁĂƐĮƌƐƚĚŝƐĐŽǀĞƌĞĚĨŽƌŝƚƐƉŽƚĞŶƟĂůĂƐƐŽĐŝĂƟŽŶǁŝƚŚŐĂƐƚƌŽŝŶƚĞƐƟŶĂů cancers65, 66ĂŶĚƌĞŵĂŝŶƐƉŽŽƌůLJƐƚƵĚŝĞĚŝŶƚŚĞŶĞƌǀŽƵƐƐLJƐƚĞŵĐŽŶƚĞdžƚ͘/ŶƐƚƵĚŝĞƐŽĨďŽƚŚ

vertebrates and invertebrates, receptor protein tyrosine phosphatases have been strongly implicated as key neural cell adhesion receptors, with roles in neurodevelopment and ƐLJŶĂƉƟĐĨƵŶĐƟŽŶ͕ĂŶĚŽƚŚĞƌŵĞŵďĞƌƐŽĨƚŚŝƐĨĂŵŝůLJŚĂǀĞďĞĞŶŝŵƉůŝĐĂƚĞĚŝŶŶƵŵĞƌŽƵƐ neuropsychiatric disorders.67 In Drosophila͕ZEŝͲŵĞĚŝĂƚĞĚŬŶŽĐŬĚŽǁŶŽĨƚŚĞĐŽŶƐĞƌǀĞĚ PTPRH ortholog, Ptp10D͕ĞŶŚĂŶĐĞĚɲͲƐLJŶƵĐůĞŝŶͲƚƌŝŐŐĞƌĞĚƌĞƟŶĂůĚĞŐĞŶĞƌĂƟŽŶ͖ďƵƚǁĂƐ

ŶŽƚ ĂƐƐŽĐŝĂƚĞĚ ǁŝƚŚ ƐƵďƐƚĂŶƟĂů ŶĞƵƌŽƚŽdžŝĐŝƚLJ ŝŶĚĞƉĞŶĚĞŶƚ ŽĨ ɲͲƐLJŶƵĐůĞŝŶ ĞdžƉƌĞƐƐŝŽŶ͘

Ptp10D ŵƵƚĂŶƚ ŇŝĞƐ ĂƌĞ ĂůƐŽ ǀŝĂďůĞ ĂŶĚ ĨĞƌƟůĞ ďƵƚ ĚĞŵŽŶƐƚƌĂƚĞ ůŽŶŐͲƚĞƌŵ ŵĞŵŽƌLJ

ĚĞĮĐŝƚƐŝŶďĞŚĂǀŝŽƌĂůĂƐƐĂLJƐ͘68 More recent studies further implicated Ptp10D in

(24)

6

ĐŽŶƐŝƐƚĞŶƚǁŝƚŚŽƵƌĮŶĚŝŶŐƐƚŚĂƚŚƵŵĂŶPTPRH ƉĂƌƟĐŝƉĂƚĞƐŝŶĂƐƵďƐƚĂŶƟĂŶŝŐƌĂŐĞŶĞ ĐŽͲĞdžƉƌĞƐƐŝŽŶ ŶĞƚǁŽƌŬ ƐƚƌŽŶŐůLJ ĞŶƌŝĐŚĞĚ ĨŽƌ ŽůŝŐŽĚĞŶĚƌŽĐLJƚĞ ŵĂƌŬĞƌƐ͘ ĞƐŝĚĞƐ ŽƵƌ ĚŝƐĐŽǀĞƌLJŽĨŚŽŵŽnjLJŐŽƵƐ>Ž&ŝŶPTPRH͕ĨƵƌƚŚĞƌĂŶĂůLJƐĞƐŽĨƚŚĞ/W't^ĚĂƚĂƐĞƚ͕ĂŶĚ ƚŚĞƐƵďƐƚĂŶƟĂůůLJůĂƌŐĞƌ͕ŝŶĚĞƉĞŶĚĞŶƚEĞƵƌŽyĐŽŚŽƌƚ͕ŝŵƉůŝĐĂƚĞĂďƵƌĚĞŶŽĨƌĂƌĞǀĂƌŝĂŶƚƐ ĂƚƚŚŝƐůŽĐƵƐŝŶĂƐƐŽĐŝĂƟŽŶǁŝƚŚWƐƵƐĐĞƉƟďŝůŝƚLJ͘ ɲͲƐLJŶƵĐůĞŝŶͲŝŶĚƵĐĞĚ ŶĞƵƌŽĚĞŐĞŶĞƌĂƟŽŶ ǁĂƐ ĂůƐŽ ĞŶŚĂŶĐĞĚ ďLJ ŬŶŽĐŬĚŽǁŶ ŽĨ

CG32191, a Drosophila homolog of ARSB͘ZEŝƚƌĂŶƐŐĞŶŝĐůŝŶĞƐƚĂƌŐĞƟŶŐϯŽƚŚĞƌĐŽŶƐĞƌǀĞĚ

ŇLJARSB ŚŽŵŽůŽŐƐƐŚŽǁĞĚĐŽŶƐŝƐƚĞŶƚŝŶƚĞƌĂĐƟŽŶƐǁŝƚŚɲͲƐLJŶƵĐůĞŝŶ;^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞ ϲĂŶĚϳͿ͘/ŶƚŚĞ/W'ĐŽŚŽƌƚ͕ǁĞĚŝƐĐŽǀĞƌĞĚϰWĐĂƐĞƐŚŽŵŽnjLJŐŽƵƐĨŽƌĂǀĂƌŝĂŶƚƉƌĞĚŝĐƚĞĚ ƚŽ ĚŝƐƌƵƉƚ ƐƉůŝĐŝŶŐ ŽĨ ĞdžŽŶƐ ϭ ĂŶĚ Ϯ ŝŶ ARSB͘ ůƚŚŽƵŐŚ ƚŚĞ ŝĚĞŶƟĮĞĚ ǀĂƌŝĂŶƚ ŚĂƐ ŶŽƚ ƉƌĞǀŝŽƵƐůLJďĞĞŶĚŽĐƵŵĞŶƚĞĚŝŶdž͕ǁĞŝĚĞŶƟĮĞĚĂƐŝŶŐůĞ/W'ĐŽŶƚƌŽůŚŽŵŽnjLJŐŽƚĞ͘ ĚĚŝƟŽŶĂůĞǀŝĚĞŶĐĞƐƵƉƉŽƌƟŶŐĂƐƐŽĐŝĂƟŽŶŽĨƚŚĞARSBŐĞŶĞǁŝƚŚWƐƵƐĐĞƉƟďŝůŝƚLJĐŽŵĞƐ from burden analysis in the independent NeuroX cohort. The surprisingly common ARSB ƐƉůŝĐŝŶŐǀĂƌŝĂŶƚ;ƌƐϭϯϴϮϳϵϬϮϬ͕D&сϬ͘ϬϲϱŝŶ/W'ͿŝƐĂƐŝŶŐůĞŶƵĐůĞŽƟĚĞŝŶƐĞƌƟŽŶĂůůĞůĞ ǁŝƚŚŝŶ Ă ƉŽůLJͲ ƌĞƉĞĂƚ͕ ǁŚŝĐŚ ǁĞ ƐƉĞĐƵůĂƚĞ ŵŝŐŚƚ ůĞĂĚ ƚŽ ŝŶĞĸĐŝĞŶƚ ĐĂƉƚƵƌĞ ŝŶ ƉƌŝŽƌ t^ĂŶĚƉŽƐƐŝďůLJĞdžƉůĂŝŶƚŚĞĂďƐĞŶĐĞŽĨƚŚŝƐǀĂƌŝĂŶƚĨƌŽŵdžĂŶĚƚŚĞϭϬϬϬ'ĞŶŽŵĞƐ ƉƌŽũĞĐƚƌĞĨĞƌĞŶĐĞ͘ůůϰWĐĂƐĞƐŝŶŽƵƌĚĂƚĂǁŝƚŚƚŚĞŚŽŵŽnjLJŐŽƵƐARSB splicing variant ǁĞƌĞ ĐŽŶĮƌŵĞĚ ďLJ ^ĂŶŐĞƌ ƐĞƋƵĞŶĐŝŶŐ͘ /ŶƚƌŝŐƵŝŶŐůLJ, ŵƵƚĂƟŽŶƐ ŝŶ ARSB, encoding the ůLJƐŽƐŽŵĂůĞŶnjLJŵĞƌLJůƐƵůĨĂƚĂƐĞ͕ĂƌĞĂƐƐŽĐŝĂƚĞĚǁŝƚŚƚŚĞƌĞĐĞƐƐŝǀĞůLJƐŽƐŽŵĞĚŝƐŽƌĚĞƌ͕ DƵĐŽƉŽůLJƐĂĐĐŚĂƌŝĚŽƐŝƐƚLJƉĞs/;DW^s/͕ĂůƐŽĐĂůůĞĚDĂƌŽƚĞĂƵdžͲ>ĂŵLJƐLJŶĚƌŽŵĞͿ͕ŝŶǁŚŝĐŚ the glycosaminoglycan, dermatan sulfate, accumulates causing skeletal dysplasia and ŽƚŚĞƌ ŚĞƚĞƌŽŐĞŶĞŽƵƐ ŵĂŶŝĨĞƐƚĂƟŽŶƐ͘70 ^ƵďƐƚƌĂƚĞ ĂĐĐƵŵƵůĂƟŽŶ ĂŶĚ ĂƐƐŽĐŝĂƚĞĚ ĐĞůůƵůĂƌ

stress has been reported to induce markers of impaired autophagy and mitochondrial ĚLJƐĨƵŶĐƟŽŶ ŝŶ ARSB ĚĞĮĐŝĞŶƚ ĮďƌŽďůĂƐƚƐ ĨƌŽŵ DW^ s/ ƉĂƟĞŶƚƐ͕ ĂƐ ŝŶ ŽƚŚĞƌ ůLJƐŽƐŽŵĂů disorders.71, 72 /ŵƉŽƌƚĂŶƚůLJ͕ DĂƌŽƚĞĂƵdžͲ>ĂŵLJ ĐĂŶ ďĞ ĐŚĂƌĂĐƚĞƌŝnjĞĚ ďLJ ŵŝŶŝŵĂů Žƌ ĞǀĞŶ

absent clinical signs, leading to incidental discovery or diagnosis in adulthood, and such ŵŝůĚ ƉŚĞŶŽƚLJƉĞƐ ŚĂǀĞ ďĞĞŶ ƐƵŐŐĞƐƚĞĚ ƚŽ ĂĐĐŽŵƉĂŶLJ ƉĂƌƟĂů >Ž& ǁŝƚŚ ƉƌĞƐĞƌǀĞĚ ůŽǁͲ ůĞǀĞůZ^ĞŶnjLJŵĂƟĐĂĐƟǀŝƚLJ͘70, 73, 74^ŝŵŝůĂƌŐĞŶŽƚLJƉĞͲƉŚĞŶŽƚLJƉĞƌĞůĂƟŽŶƐŚŝƉƐŚĂǀĞďĞĞŶ

ĚŽĐƵŵĞŶƚĞĚĨŽƌŽƚŚĞƌůLJƐŽƐŽŵĂůͲƐƚŽƌĂŐĞĚŝƐŽƌĚĞƌƐ͕ŝŶĐůƵĚŝŶŐ'ĂƵĐŚĞƌĚŝƐĞĂƐĞ͕ǁŚŝĐŚŚĂƐ established links with PD risk.75, 76tŚŝůĞĂĨƵůůĂĐĐŽƵŶƟŶŐŝƐŽƵƚƐŝĚĞƚŚĞƐĐŽƉĞŽĨƚŚŝƐƐƚƵĚLJ͕

ĂƚůĞĂƐƚϭŽĨƚŚĞϯ/W'ĐĂƐĞƐĨŽƌǁŚŝĐŚƌĞĐŽƌĚƐǁĞƌĞĂǀĂŝůĂďůĞƌĞǀĞĂůĞĚĐůŝŶŝĐĂůĨĞĂƚƵƌĞƐ ƉŽƚĞŶƟĂůůLJŽǀĞƌůĂƉƉŝŶŐǁŝƚŚDW^s/͘

(25)

6

ƚŚĞ ƉŽƐƐŝďŝůŝƚLJ ŽĨ ĚŽŵŝŶĂŶƚůLJͲĂĐƟŶŐ ĂůůĞůĞƐ͖ ŚŽǁĞǀĞƌ͕ ƚŚŝƐ ƐƵďƐƚĂŶƟĂůůLJ ŝŶĐƌĞĂƐĞƐ ƚŚĞ ŶƵŵďĞƌŽĨǀĂƌŝĂŶƚƐƚŽĐŽŶƐŝĚĞƌĂŶĚĂůƐŽƉŽƚĞŶƟĂůůLJĐŽŵƉůŝĐĂƚĞƐĨƵŶĐƟŽŶĂůƐƚƵĚŝĞƐ;ŝ͘Ğ͘ ĐŽŵƉĂƌĞĚ ǁŝƚŚ ůŽƐƐͲŽĨͲĨƵŶĐƟŽŶ ƐĐƌĞĞŶŝŶŐ ƵƐŝŶŐ ZEͲŝŶƚĞƌĨĞƌĞŶĐĞͿ͘ KƵƌ ƐƚƵĚLJ ĚĞƐŝŐŶ ĞdžĐůƵĚĞĚĐŽŶƐŝĚĞƌĂƟŽŶŽĨŵĂŶLJŶŽŶͲƐLJŶŽŶLJŵŽƵƐǀĂƌŝĂŶƚƐƚŚĂƚĐŽƵůĚƉŽƚĞŶƟĂůůLJĐĂƵƐĞ ůŽƐƐͲ;ŽƌŐĂŝŶͲͿŽĨŐĞŶĞĨƵŶĐƟŽŶ͕ĂůŽŶŐǁŝƚŚĐĞƌƚĂŝŶŶŽŶͲƚƌƵŶĐĂƟŶŐ͕ĨƌĂŵĞƐŚŝŌŝŶŐĂůůĞůĞƐ ;ƐĞĞDĞƚŚŽĚƐͿ͘ǀĞŶǁŝƚŚĨĂŝƌůLJƐƚƌŝŶŐĞŶƚĐƌŝƚĞƌŝĂĨŽƌǀĂƌŝĂŶƚĮůƚĞƌŝŶŐĂŶĚƚŚĞĂƐƐƵŵƉƟŽŶ ŽĨ ƌĞĐĞƐƐŝǀĞ ŝŶŚĞƌŝƚĂŶĐĞ͕ ǁĞ ĨŽƵŶĚ ĞǀŝĚĞŶĐĞ ĨŽƌ ƐƵďƐƚĂŶƟĂů ĞƟŽůŽŐŝĐ ŚĞƚĞƌŽŐĞŶĞŝƚLJ͘ /ŵƉƌŽǀĞĚĐŽŶĮĚĞŶĐĞĨŽƌĚŝƐĐŽǀĞƌLJŽĨWĐĂƵƐĂůǀĂƌŝĂŶƚƐǁŝůůůŝŬĞůLJĐŽŵĞĨƌŽŵWt^ ĐŽŚŽƌƚƐǁŝƚŚƐŝŐŶŝĮĐĂŶƚůLJĞŶŚĂŶĐĞĚƐĂŵƉůĞƐŝnjĞƐ͕ĂƐǁĞůůĂƐŝŶĐƌĞĂƐĞĚŶƵŵďĞƌƐŽĨĂĚƵůƚ ĐŽŶƚƌŽůƐ͕ ŝŶĐůƵĚŝŶŐ ƚŚŽƐĞ ǁŝƚŚ ĐĂƌĞĨƵů ŶĞƵƌŽůŽŐŝĐĂů ĂƐƐĞƐƐŵĞŶƚƐ ƚŽ ĞdžĐůƵĚĞ ŵŝůĚ W ƐLJŵƉƚŽŵƐ͘/ŶĚĞĞĚ͕ǁŚŝůĞŵŽƐƚŽĨƚŚĞǀĂƌŝĂŶƚƐŝŵƉůŝĐĂƚĞĚďLJƚŚĞ/W't^ĐŽŚŽƌƚǁĞƌĞ ƌĞƉƌĞƐĞŶƚĞĚ Ăƚ ůŽǁ ĨƌĞƋƵĞŶĐŝĞƐ ǁŝƚŚŝŶ ƚŚĞ ůĂƌŐĞƐƚ ĂǀĂŝůĂďůĞ ƉƵďůŝĐ ĚĂƚĂďĂƐĞ͕ dž77, 78͖ ŚŽǁĞǀĞƌ͕ǁĞŚĂǀĞŶŽŝŶĨŽƌŵĂƟŽŶĂďŽƵƚƉŽƚĞŶƟĂůWŵĂŶŝĨĞƐƚĂƟŽŶƐŝŶƐƵĐŚŝŶĚŝǀŝĚƵĂůƐŽƌ even subject age.

^ŝŶĐĞŶŽƐŝŶŐůĞĐĞůůƵůĂƌŽƌĂŶŝŵĂůĞdžƉĞƌŝŵĞŶƚĂůŵŽĚĞůŝƐĞdžƉĞĐƚĞĚƚŽƵŶŝǀĞƌƐĂůůLJ ƌĞĐĂƉŝƚƵůĂƚĞĂůůƉŽƚĞŶƟĂůĨĂĐĞƚƐŽĨĚŝƐĞĂƐĞďŝŽůŽŐLJ͕ǁĞŶŽƚĞƚŚĂƚƚŚĞĞŵƉůŽLJĞĚĨƵŶĐƟŽŶĂů ƐĐƌĞĞŶŝŶŐĂƐƐĂLJƐĂƌĞƉŽƚĞŶƟĂůůLJůŝĂďůĞƚŽĨĂůƐĞŶĞŐĂƟǀĞŽƌƉŽƐŝƟǀĞĮŶĚŝŶŐƐ͘/ŵƉŽƌƚĂŶƚůLJ͕ ĞdžƉĞƌŝŵĞŶƚĂů ĞǀŝĚĞŶĐĞ ŽĨ Ă ŐĞŶĞƟĐ ŝŶƚĞƌĂĐƟŽŶ ǁŝƚŚ ĞŝƚŚĞƌ ŵŝƚŽĐŚŽŶĚƌŝĂů ĚLJŶĂŵŝĐƐ Žƌ ɲͲƐLJŶƵĐůĞŝŶŵĞĚŝĂƚĞĚŶĞƵƌŽŶĂůŝŶũƵƌLJŝŶŽƵƌƐĐƌĞĞŶŝŶŐĂƐƐĂLJƐĐĂŶŶŽƚŝŶŝƐŽůĂƟŽŶĐŽŶĮƌŵ ĂƌŽůĞŝŶĚŝƐĞĂƐĞĐĂƵƐĂƟŽŶ͕ďƵƚƌĂƚŚĞƌƐĞƌǀĞƐƚŽƉƌŝŽƌŝƟnjĞŐĞŶĞƐĨŽƌĨƵƚƵƌĞŝŶǀĞƐƟŐĂƟŽŶ͘ KƵƚ ŽĨ ƚŚĞ Ϯϳ ĐĂŶĚŝĚĂƚĞ ŐĞŶĞƐ ŝŵƉůŝĐĂƚĞĚ ŝŶ ƚŚĞ /W' t^ ĚŝƐĐŽǀĞƌLJ ĂŶĂůLJƐŝƐ͕ ϭϰ ǁĞƌĞŝŶƐƵĸĐŝĞŶƚůLJĐŽŶƐĞƌǀĞĚĨŽƌĨŽůůŽǁͲƵƉŝŶɲͲƐLJŶƵĐůĞŝŶƚƌĂŶƐŐĞŶŝĐŇŝĞƐ͘tŚŝůĞƐŝŵƉůĞ animal models, including Drosophila or C. elegans͕ŚĂǀĞŵĂĚĞŝŵƉŽƌƚĂŶƚĐŽŶƚƌŝďƵƟŽŶƐ ƚŽ ŽƵƌ ƵŶĚĞƌƐƚĂŶĚŝŶŐ ŽĨ W ƉĂƚŚŽŐĞŶĞƐŝƐ͕ ƐĞůĞĐƚĞĚ ŵĞĐŚĂŶŝƐŵƐ͕ ƐƵĐŚ ĂƐ ƚŚĞ ƉŽƚĞŶƟĂů ƌŽůĞŽĨĂĚĂƉƟǀĞŝŵŵƵŶŝƚLJŽƌďĂƐĂůŐĂŶŐůŝĂĐŝƌĐƵŝƚĚLJƐĨƵŶĐƟŽŶ͕ĐĂŶŶŽƚďĞĂĚĚƌĞƐƐĞĚŝŶ invertebrates.79, 80tĞǁĞƌĞƵŶĂďůĞƚŽĐŽŶĮƌŵŽƵƌĮŶĚŝŶŐƐĨƌŽŵDrosophila in a published C. elegans ŵŽĚĞůŽĨɲͲƐLJŶƵĐůĞŝŶƚŽdžŝĐŝƚLJ͘/ŶƚŚĞĨƵƚƵƌĞ͕ŝƚǁŝůůĂůƐŽďĞŝŵƉŽƌƚĂŶƚƚŽĞdžĂŵŝŶĞ

(26)

6

KE>h^/KE

tĞ ŚĂǀĞ ŝĚĞŶƟĮĞĚ ϱ ĞdžĐĞůůĞŶƚ W ŐĞŶĞ ĐĂŶĚŝĚĂƚĞƐ ;'Wd,Ϯ>͕ h,Z&ϭWϭ>͕ WdWZ,͕

ARSB and VPS13CͿ͕ŚĂƌďŽƌŝŶŐŚŽŵŽnjLJŐŽƵƐŽƌĐŽŵƉŽƵŶĚŚĞƚĞƌŽnjLJŐŽƵƐ>Ž&ǀĂƌŝĂŶƚƐŝŶW

ĞdžŽŵĞƐ͕ ĚĞŵŽŶƐƚƌĂƟŶŐ ĨƵŶĐƟŽŶĂů ŝŶƚĞƌĂĐƟŽŶƐ ǁŝƚŚ ŵŝƚŽĐŚŽŶĚƌŝĂů ĂŶĚͬŽƌ ɲͲƐLJŶƵĐůĞŝŶͲ ŵĞĚŝĂƚĞĚŵĞĐŚĂŶŝƐŵƐ͕ĂŶĚƐƵƉƉŽƌƚĞĚďLJĞǀŝĚĞŶĐĞŽĨƌĞƉůŝĐĂƟŽŶŝŶŝŶĚĞƉĞŶĚĞŶƚŚƵŵĂŶ datasets. The recent report21ŽĨĂĚĚŝƟŽŶĂůWĨĂŵŝůŝĞƐƐĞŐƌĞŐĂƟŶŐ>Ž&ŵƵƚĂƟŽŶƐŝŶVPS13C

ĂůŽŶŐǁŝƚŚŽƚŚĞƌĞdžƉĞƌŝŵĞŶƚƐƐƵƉƉŽƌƟŶŐĂƌŽůĞŝŶŵŝƚŽĐŚŽŶĚƌŝĂůŵĞĐŚĂŶŝƐŵƐƐŝŐŶŝĮĐĂŶƚůLJ strengthens the evidence in support of this gene in PD, and validates our overall approach. dŚĞƐĞůŽĐŝĂƌĞǁĞůůͲƐƵŝƚĞĚĨŽƌĨƵƌƚŚĞƌĨƵƚƵƌĞĞīŽƌƚƐĚŝƌĞĐƚĞĚĂƚŚƵŵĂŶŐĞŶĞƟĐƌĞƉůŝĐĂƟŽŶ ĂŶĚŝŶͲĚĞƉƚŚĨƵŶĐƟŽŶĂůĚŝƐƐĞĐƟŽŶ͘tĞĂůƐŽŵĂŬĞĂǀĂŝůĂďůĞƌĞƐƵůƚƐ͕ŝŶĐůƵĚŝŶŐĮŶĚŝŶŐƐĨƌŽŵ ŚƵŵĂŶŐĞŶĞƟĐĂŶĂůLJƐĞƐĂŶĚĨƵŶĐƟŽŶĂůƐƚƵĚŝĞƐŝŶŵŽƐƚĐĂƐĞƐ͕ŽŶϮϮŽƚŚĞƌƉƌŽŵŝƐŝŶŐůŽĐŝ͘ dŚĞƐĞĚĂƚĂǁŝůůƐĞƌǀĞĂƐĂǀĂůƵĂďůĞƌĞĨĞƌĞŶĐĞĨŽƌŽŶŐŽŝŶŐĂŶĚĨƵƚƵƌĞWŐĞŶĞƟĐƐƚƵĚŝĞƐ͘ DŽƌĞďƌŽĂĚůLJ͕ŽƵƌĂƉƉƌŽĂĐŚŽĨŝŶƚĞŐƌĂƟŶŐŚŝŐŚͲƚŚƌŽƵŐŚƉƵƚƐĞƋƵĞŶĐŝŶŐŝŶWĐĂƐĞͬĐŽŶƚƌŽů ĐŽŚŽƌƚƐ ǁŝƚŚ ƉĂƌĂůůĞů ƐLJƐƚĞŵĂƟĐ ƐĐƌĞĞŶŝŶŐ ŝŶ ĐĞůůƐ ĂŶĚ ŵŽĚĞů ŽƌŐĂŶŝƐŵƐ ĨŽƌ ĨƵŶĐƟŽŶĂů ƉƌŝŽƌŝƟnjĂƟŽŶĞdžĞŵƉůŝĮĞƐĂƉŽǁĞƌĨƵůĞdžƉĞƌŝŵĞŶƚĂůƐƚƌĂƚĞŐLJǁŝƚŚŐƌĞĂƚƉƌŽŵŝƐĞĨŽƌĨƵƚƵƌĞ genomic studies of PD and other human disorders.

Dd,K^

'ĞŶĞƟĐĂŶĂůLJƐĞƐ Whole exome sequencing

tŚŽůĞĞdžŽŵĞƐĞƋƵĞŶĐŝŶŐ;t^ͿǁĂƐƉĞƌĨŽƌŵĞĚŽŶϭ͕ϭϰϴWĐĂƐĞƐĂŶĚϱϬϯŶĞƵƌŽůŽŐŝĐĂůůLJ ŚĞĂůƚŚLJĐŽŶƚƌŽůƐŽĨƵƌŽƉĞĂŶĚĞƐĐĞŶƚ͘ůůƐƵďũĞĐƚƐƉƌŽǀŝĚĞĚǁƌŝƩĞŶŝŶĨŽƌŵĞĚĐŽŶƐĞŶƚ͘ ZĞůĞǀĂŶƚůŽĐĂůĞƚŚŝĐĂůĐŽŵŵŝƩĞĞƐĨŽƌŵĞĚŝĐĂůƌĞƐĞĂƌĐŚĂƉƉƌŽǀĞĚƉĂƌƟĐŝƉĂƟŽŶŝŶŐĞŶĞƟĐ ƐƚƵĚŝĞƐ͘ /Ĩ W ƉĂƟĞŶƚƐ ǁĞƌĞ ƉƌĞƐĐƌĞĞŶĞĚ ĨŽƌ ŬŶŽǁŶ ƉĂƚŚŽŐĞŶŝĐ ŵƵƚĂƟŽŶƐ͕ ƚŚĞLJ ǁĞƌĞ ĞdžĐůƵĚĞĚĨŽƌĞdžŽŵĞƐĞƋƵĞŶĐŝŶŐǁŚĞŶŚĂǀŝŶŐƐƵĐŚĂǀĂƌŝĂŶƚ͘dŚĞĐĂƐĞƐǁĞƌĞĚŝĂŐŶŽƐĞĚ ǁŝƚŚ W Ăƚ Ă ƌĞůĂƟǀĞůLJ LJŽƵŶŐ ĂǀĞƌĂŐĞ ĂŐĞ ŽĨ ϰϬ͘ϲ LJĞĂƌƐ ;ƌĂŶŐĞ ϲͲϱϲ LJĞĂƌƐͿ͕ ŽĨ ǁŚŝĐŚ ĂƉƉƌŽdžŝŵĂƚĞůLJϯϳйƌĞƉŽƌƚĞĚĂƉŽƐŝƟǀĞĨĂŵŝůLJŚŝƐƚŽƌLJ͘dŚĞŶĞƵƌŽůŽŐŝĐĂůůLJŚĞĂůƚŚLJĐŽŶƚƌŽůƐ ĂƌĞ ŽŶ ĂǀĞƌĂŐĞ ϰϴ͘Ϯ LJĞĂƌƐ ŽĨ ĂŐĞ ;ƌĂŶŐĞ ϭϬͲϵϳ LJĞĂƌƐͿ͘  ŵŽƌĞ ĞdžƚĞŶƐŝǀĞ ŽǀĞƌǀŝĞǁ ŽĨ ĚĞŵŽŐƌĂƉŚŝĐŝŶĨŽƌŵĂƟŽŶŝƐƌĞƉŽƌƚĞĚŝŶ^ƵƉƉůĞŵĞŶƚĂƌLJ&ŝŐƵƌĞϴ͘ ƵĞƚŽŝŵƉƌŽǀĞŵĞŶƚƐŽĨƚŚĞĞdžŽŵĞƐĞƋƵĞŶĐŝŶŐƉƌŽƚŽĐŽůŽǀĞƌƟŵĞ͕ƚŚĞĞdžŽŵĞ ƐĂŵƉůĞůŝďƌĂƌŝĞƐǁĞƌĞƉƌĞƉĂƌĞĚǁŝƚŚĚŝīĞƌĞŶƚĐĂƉƚƵƌĞŬŝƚƐ͘&ŽƌƚŚŝƐƐƚƵĚLJƚŚƌĞĞĚŝīĞƌĞŶƚ ĐĂƉƚƵƌĞŬŝƚƐǁĞƌĞƵƐĞĚ͗/ůůƵŵŝŶĂdƌƵ^ĞƋ;^ĂŶŝĞŐŽ͕ĂůŝĨŽƌŶŝĂͿ;ϲϮDďƚĂƌŐĞƚͿ͕ZŽĐŚĞ;ĂƐĞů͕ ^ĐŚǁŝƚnjĞƌůĂŶĚͿEŝŵďůĞŐĞŶ^ĞƋĂƉ;ϰϰ͘ϭDďƚĂƌŐĞƚͿĂŶĚŐŝůĞŶƚ;^ĂŶƚĂůĂƌĂ͕ĂůŝĨŽƌŶŝĂͿ ^ƵƌĞ^ĞůĞĐƚ;ϯϳ͘ϲDďƚĂƌŐĞƚͿ͕ǁŚŝĐŚĐĂƉƚƵƌĞĚϵϲй͕ϴϭйĂŶĚϳϭйŽĨƚŚĞƚĂƌŐĞƚĞĚĞdžŽŵĞĂƚ ůĞĂƐƚϭϬƟŵĞƐƌĞƐƉĞĐƟǀĞůLJ;^ƵƉƉůĞŵĞŶƚĂƌLJdĂďůĞϭϭͿ͘džŽŵĞůŝďƌĂƌŝĞƐǁĞƌĞƐĞƋƵĞŶĐĞĚŽŶĂ HiSeq 2000 (Illumina, San Diego, California). The Burrows Wheeler Aligner MEM v0.7.9.a 81

(27)

6

ŚŐϭϵ͘ tĞ ĐĂůůĞĚ ƚŚĞ ƐŝŶŐůĞ ŶƵĐůĞŽƟĚĞ ǀĂƌŝĂŶƚƐ ;^EsƐͿ ĂŶĚ ŝŶƐĞƌƟŽŶƐͬĚĞůĞƟŽŶƐ ;ŝŶĚĞůƐͿ ĨŽƌĂůůƐĂŵƉůĞƐƐŝŵƵůƚĂŶĞŽƵƐůLJƵƐŝŶŐ'ĞŶŽŵĞŶĂůLJƐŝƐdŽŽůŬŝƚ;'d<Ϳϯ͘dž͕82 followed by ƚŚĞĞdžĐůƵƐŝŽŶŽĨůŽǁͲƋƵĂůŝƚLJǀĂƌŝĂŶƚĐĂůůƐŶŽƚƉĂƐƐŝŶŐƚŚĞĚĞĨĂƵůƚ'd<ĮůƚĞƌƐ͘/ŶĚŝǀŝĚƵĂů ŐĞŶŽƚLJƉĞƐ ǁĞƌĞ ƌĞŵŽǀĞĚ ǁŝƚŚ ŐĞŶŽƚLJƉĞ ƋƵĂůŝƚLJ WŚƌĞĚͲƐĐŽƌĞƐ ďĞůŽǁ ϰϬ͘ EEKsZ83 ǁĂƐ ĂƉƉůŝĞĚ ƚŽ ĂŶŶŽƚĂƚĞ ƚŚĞ ǀĂƌŝĂŶƚƐ ǁŝƚŚ ŝŶĨŽƌŵĂƟŽŶ ĐŽŶĐĞƌŶŝŶŐ ǀĂƌŝĂŶƚ ƚLJƉĞ ;ǀĂůŝĚ ĂŶŶŽƚĂƟŽŶƐǁŚĞŶZĞĨƐĞƋŝŶĐŽŶĐŽƌĚĂŶĐĞǁŝƚŚh^Ϳ͕D&ŝŶƚŚĞŐĞŶĞƌĂůƉŽƉƵůĂƟŽŶĂŶĚ ƉƌĞĚŝĐƟŽŶƐŽĨƚŚĞǀĂƌŝĂŶƚ͛ƐĞīĞĐƚŽŶŐĞŶĞĨƵŶĐƟŽŶ͕ŝŵƉůĞŵĞŶƟŶŐ͘84 sĂƌŝĂŶƚŝĚĞŶƟĮĐĂƟŽŶŝŶ/W't^ĚĂƚĂƐĞƚ

Considering the worldwide prevalence of 0.041% for PD in the age range of 40 to 49 years,20

ǁĞƐĞůĞĐƚĞĚƌĂƌĞǀĂƌŝĂŶƚƐǁŝƚŚĂD&фϭй;ĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽĂŚŽŵŽnjLJŐŽƵƐĨƌĞƋƵĞŶĐLJ ŽĨϬ͘ϬϭйͿŝŶƚŚĞƵƌŽƉĞĂŶƉŽƉƵůĂƟŽŶ͘ĞĐĂƵƐĞƚŚĞƐƉĞĐŝĮĞĚϬ͘ϬϰϭйŽĨƚŚĞƉŽƉƵůĂƟŽŶ ǁŝƚŚLJŽƵŶŐͲŽŶƐĞƚWĂƌŬŝŶƐŽŶ͛ƐĚŝƐĞĂƐĞ;zKWͿŝƐŶŽƚĐĂƵƐĞĚďLJŽŶĞƐŚĂƌĞĚŐĞŶĞƟĐĨĂĐƚŽƌ͕ ǁĞ ĞdžƉĞĐƚ Ă ŚŽŵŽnjLJŐŽƵƐ ĨƌĞƋƵĞŶĐLJ ŽĨ Ϭ͘Ϭϭй ƚŽ ďĞ ĂŶ ĂĚĞƋƵĂƚĞ ĐƵƚͲŽī͕ ǁŚŝĐŚ ǁŽƵůĚ ďĞĂďůĞƚŽĚĞƚĞƌŵŝŶĞǀĂƌŝĂŶƚƐƉƌĞƐĞŶƚŝŶĂƉƉƌŽdžŝŵĂƚĞůLJϮϱйŽĨƚŚĞzKWƉŽƉƵůĂƟŽŶ͘Ɛ ĂĐŽŵƉĂƌŝƐŽŶƚŽƚŚĞŵŽƐƚĐŽŵŵŽŶŐĞŶĞƟĐĐĂƵƐĞŽĨzKW͕parkin,85 the most frequent

ŵƵƚĂƟŽŶŝƐĂŶĞdžŽŶϯĚĞůĞƟŽŶ͕ǁŚŝĐŚŚĂƐďĞĞŶŝĚĞŶƟĮĞĚŝŶϭϲ͘ϰйŽĨzKWƉĂƟĞŶƚƐ͘86

hƐŝŶŐ EEKsZ͕83 Ăůů ǀĂƌŝĂŶƚƐ ǁĞƌĞ ĂŶŶŽƚĂƚĞĚ ǁŝƚŚ D& ŝŶĨŽƌŵĂƟŽŶ ŽĨ ^WϲϱϬϬƐŝ

;ƵƌŽƉĞĂŶ ŵĞƌŝĐĂŶ ƉŽƉƵůĂƟŽŶͿ͕87 ϭϬϬϬ 'ĞŶŽŵĞƐ WƌŽũĞĐƚ ;ƵƌŽƉĞĂŶ ƉŽƉƵůĂƟŽŶ ŽĨ

April 2012 version)88ĂŶĚƚŚĞdžŽŵĞŐŐƌĞŐĂƟŽŶŽŶƐŽƌƟƵŵ;džͿďƌŽǁƐĞƌ;ŶŽŶͲ&ŝŶŝƐŚ

ƵƌŽƉĞĂŶƉŽƉƵůĂƟŽŶͿ͘77, 78tŚĞŶŶŽƉƵďůŝĐĂůůĞůĞĨƌĞƋƵĞŶĐLJǁĂƐĂǀĂŝůĂďůĞĨŽƌŚŽŵŽnjLJŐŽƵƐ

Referenties

GERELATEERDE DOCUMENTEN

[r]

[r]

[r]

Bij deze groep werden geen slaap-apnoes gezien, verder werd er bij 7 mensen SOREM gezien en bij 7 mensen REM slaap tij- dens dutjes overdag (helaas wordt niet vermeld hoe vaak

Koelman vertaalde: Ettelijke gronden van de

\]pe\TTQOP PY^ ^PVQ PY^q^PVQ ZPQR~YWUPY^ ZPQR~YWU^PVZQPQR~YWUPY^q^PVQ nmmrmmmvwwwwwwwwwwwwwwUno{umm vwxyxxvwwwwwwwwwwwwwwwwwwwn Uo{umm vwwwwwwwwwwwwwwwwU

he raad van de gemeente Tynaarlo; burgemeester en wethouders d.d.11 mei 2021 ; e raad van de gemeente Tynaarlo; n de gemeente Tynaarlo;i 2021 ;e raad van de gemeente Tynaarlo; oe

Hoe weet u als college dat het aanbod van deze aanbieders beter is. &gt; dan het aanbod van overige, niet